U.S. patent application number 14/335010 was filed with the patent office on 2015-06-18 for color-produing diagnostic systems, reagents and methods.
The applicant listed for this patent is Diagnostic Innovations, LLC. Invention is credited to Victor Kovalenko.
Application Number | 20150168387 14/335010 |
Document ID | / |
Family ID | 47296679 |
Filed Date | 2015-06-18 |
United States Patent
Application |
20150168387 |
Kind Code |
A1 |
Kovalenko; Victor |
June 18, 2015 |
COLOR-PRODUING DIAGNOSTIC SYSTEMS, REAGENTS AND METHODS
Abstract
Provided herein are novel reagents and their use in
color-producing detection systems for performing diagnostic tests
and analytical assays.
Inventors: |
Kovalenko; Victor; (Saco,
ME) |
|
Applicant: |
Name |
City |
State |
Country |
Type |
Diagnostic Innovations, LLC |
Saco |
ME |
US |
|
|
Family ID: |
47296679 |
Appl. No.: |
14/335010 |
Filed: |
July 18, 2014 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
13478820 |
May 23, 2012 |
8815532 |
|
|
14335010 |
|
|
|
|
61494232 |
Jun 7, 2011 |
|
|
|
Current U.S.
Class: |
506/12 ; 435/28;
435/7.92; 525/333.5; 525/54.1; 530/363 |
Current CPC
Class: |
C08G 81/02 20130101;
G01N 2333/908 20130101; G01N 33/535 20130101; C07K 17/08 20130101;
C12Q 1/28 20130101; C07K 17/02 20130101; G01N 33/545 20130101; G01N
33/581 20130101 |
International
Class: |
G01N 33/545 20060101
G01N033/545; C12Q 1/28 20060101 C12Q001/28; C07K 17/02 20060101
C07K017/02; C07K 17/08 20060101 C07K017/08; C08G 81/02 20060101
C08G081/02 |
Claims
1. A composition of hydrogen donor polymer conjugates for dye
formation in an oxidative coupling reaction with participation of
electron acceptor/coupler, peroxide and compounds with peroxidative
activity, comprising any of the following: a) Water soluble
hydrogen donor conjugates prepared by covalent linking of hydrogen
donors to water soluble carrier polycarboxylic polymer together
with additional uncharged hydrophilic polymer; b) Water soluble
hydrogen donor conjugates prepared by covalent linking to water
soluble carrier polycarboxylic polymer together with additional
uncharged hydrophilic polymer and bio-affinity partner; c) Water
soluble hydrogen donor conjugates prepared by covalent linking to
copolymer of water soluble polycarboxylic carrier polymers with
second carrier hydrophilic protein and hydrophilic uncharged
polymer; d) Water soluble hydrogen donor conjugates prepared by
covalent linking to co-polymer of water soluble poly carboxylic
carrier polymer with hydrophilic protein, hydrophilic uncharged
polymer and bio-affinity partner; or e) Water soluble hydrogen
donor conjugates prepared by covalent linking to carrier protein
conjugated with brunched polycarboxylic oligomers and carboxylic
pendant polymers.
2. The composition of claim 1, wherein hydrogen donors for covalent
coupling are selected from the group consisting of amine-containing
compounds comprising substituted anilines, quinolines, naphthols,
and phenols, which produce dyes of different colors in a reaction
with oxidized coupler with an absorbance maximum in a range of
380-650 nm.
3. The composition of claim 1, wherein the hydrogen donors are
8-[4-amino-1-methylbutyl]-6-methoxy quinoline,
N,N-Dimethyl-1,3-phenylenediamine, N-Phenylethylenediamine, or
N-(1-Naphtyl)ethylenediamine.
4. The composition of claim 1, wherein the polycarboxylic polymers
and branched oligomers are selected from the group consisting of a
fixed number of carboxyl groups, such as ethylenediamine
tetraacetic acid, ethylene
glycol-bis(2-aminoethylether)-N,N,N',N'-tetraacetic acid, branched
pendant carboxylic polymers, and linear polymers such as
polyglutamic acid, polyaspartic acid, polyacrylic acid, polymaleic
acid, polymethacrylic acid, polyacrylamide/polyacrylic acid
copolymer, polyvinyl-maleic acid copolymer, polyethylene maleic
acid copolymers, and polyacrylic-polymaleic acid copolymer at any
combinations and molecular weights.
5. The composition of claim 1, wherein the hydrophilic uncharged
polymers are polyethylene glycols of various molecular weights
(1-20 kDa) covalently linked with carboxylic groups of both
carriers, polycarboxylic polymer and protein or with amino groups
of a carrier protein.
6. The composition of claim 1, wherein the protein carrier for
conjugation with polymers and hydrogen donors is bovine serum
albumin additionally hydrophilized by attachment of polyethylene
glycols through amino or carboxyl groups of the protein.
7. The composition of claim 1, wherein the bio-affinity partners
are components of high-affinity binding pairs, biotin, digoxigenin,
antigens, peptides, haptens, or other analyte capture reagents
participating in analyte capture directly or indirectly.
8. The composition of claim 1, wherein the water soluble hydrogen
donor polymer conjugates are covalently immobilized on carboxylate
or aminated particles.
9. The composition of claim 1, which are covalently immobilized on
particles together with hydrophilic polymers and proteins.
10. The composition of claim 1, wherein the water soluble hydrogen
donor conjugates are immobilized on particles through non-covalent
passive adsorption.
11. A method for producing colored reaction products comprising the
step of: contacting at least one hydrogen donor polymer conjugate
or particle immobilized hydrogen donor with an oxidizable coupling
reagent in the presence of peroxide and peroxidase or a
peroxidatively active substance.
12. The method of claim 11, wherein the hydrogen donor polymer
conjugate or particle immobilized hydrogen donor reagents are mixed
with soluble or particle-bound analyte capture reagents and applied
to a membrane or solid support for making diagnostic zones through
mechanism of passive adsorption or trapping into pores.
13. A method for application of a water-soluble and particle-bound
hydrogen donor conjugate of claim 1 in diagnostic tests wherein a
variety of hydrogen donor conjugates are used for generation of
multicolor result on diagnostic membranes containing multiple
diagnostic and control zones.
14. The method of claim 11, wherein the peroxide oxidizable
coupling reagent is 3-Methyl-2-benzothiazolinone hydrazone or a
derivative thereof.
15. The method of claim 11, wherein the peroxide compound is sodium
perborate, hydrogen peroxide or urea hydrogen peroxide.
16. The method of claim 11, wherein the peroxide is provided by the
conversion of a substrate of an oxidative enzyme.
17. The method of claim 11, wherein the peroxidase, exemplary
horseradish or another plant peroxidase, is a detector label in the
assay for quantitative or qualitative analysis of a test
analyte.
18. The method of claim 11, wherein formation of the colored
reaction product indicates the presence of a analyte with
peroxidative activity.
19. A method for application of a water-soluble and particle-bound
hydrogen donor conjugate of claim 1 in membrane-based diagnostic
tests where membranes are used as a media for lateral flow
chromatographic separation, vertical filtration, passive diffusion,
dip-stick, bead filtration and slide microarray assays.
Description
RELATED APPLICATIONS
[0001] This application claims priority to U.S. Provisional
Application Ser. No. 61/494,232, filed Jun. 7, 2011; the contents
of which are hereby incorporated by reference.
BACKGROUND OF THE INVENTION
[0002] Rapid diagnostic tests all employ various principles of
separation and detection of analytes on membranes. However, the
vast majority of these tests use colorimetric labels with a fixed
amount of optically active substances such as colloidal gold,
non-metal colloids, pigment particles/polymers or liposomes loaded
with dyes. Test results are usually read by visual analysis of
color intensity in diagnostic zones. The use of simple portable
scanners/densitometers was also implemented into diagnostic
practices to reduce operator mistakes in data interpretation or to
integrate point-of-care (POC) testing into database system.
However, these detection methods have inherent limitations in
sensitivity related to absorptive characteristics of these detector
labels. The analytical sensitivity of rapid tests utilizing
colorimetric labels is significantly lower than the sensitivity of
plate enzyme-linked immunoassay (ELISA), which is currently the
major method of clinical diagnostics widely applied to screenings
or confirmatory tests for diagnosis of diseases or health
conditions.
[0003] The emergence of new diagnostic markers requires more
sensitive detection systems. Numerous methods were developed to
increase the analytical sensitivity. Among them were methods
utilizing various fluorescent labels, super-paramagnetic labels,
and chemiluminescent approaches. However, most of these methods
required sophisticated equipment for reading, such as fluorometers
or magnetic readers, not readily compatible with POC applications
of these tests or accessible in low resource settings. The
availability of stable colorimetric detection systems for rapid
tests providing analytical sensitivity attained at clinical
laboratories should significantly extend the area of application of
rapid tests for cost-efficient diagnostics and other analytical
applications.
[0004] Peroxidase, in particular horseradish peroxidase (HRP), is
one of the most important enzymatic labels for detection of
analytes by various methods, such as microplate enzyme immunoassay
(EIA), Western blot, dot-blot, immunohistochemistry and
electrobiosensors. Low cost, high activity, stability,
compatibility with various biological matrices and the availability
of very stable forms of commercial substrates all make this enzyme
a very popular label for diagnostic tests and various bioanalytical
applications.
[0005] Direct detection of peroxidative activity of certain
diagnostic markers and research analytes is also an important
application for peroxidase substrate systems. One example is
detection of peroxidative activity of human hemoglobin as a marker
for color cancer. Emerging markers with peroxidative activity, such
as glutathione peroxidase and myeloperoxidase, are considered
important prognostic markers for myocardium infarction and coronary
artery disease. Many other peroxidases such as microperoxidases,
eosinophile peroxidases, uterine peroxidases, lactoperoxidases,
salivary peroxidases, thyroid peroxidases, prostaglandin H1/2
synthase and enzymes of oxidative stress (superoxide dismutase),
are potential markers for various metabolic dysfunctions.
[0006] Peroxidase substrates, which are suitable for colorimetric,
fluorescent and chemiluminescent analysis are commercially
available (e.g. from Molecular Probes/Invitrogen, Pierce and
AnaSpec). The broad spectrum of substrates available for
immunohistochemistry allows for multicolor labeling. The most
popular substrates for tests performed in microplates or tubes are
TMB (3,3',5,5'-Tetramethyl-benzidine), DAB
(3,3'-diaminodbenzidine), 1-Chloro-2-naphtol (CLN),
diaminobenzidine, and ABTS
(2,2'-Azinobis[3-ethylbenzothiazoline-6-sulfonic acid]-diammonium
salt). U.S. Pat. No. 6,960,323 also describes various urea
derivatives, which may be used as a peroxidase substrate.
[0007] The detection of a peroxidase labels in EIA tests is based
on the oxidation of a substrate with peroxidase in the presence of
a peroxide (e.g. hydrogen peroxide). This reaction generates
soluble reaction products. Precipitating substrates are commonly
used for the detection of a peroxidase label, which is bound to a
membrane (Western blot, dot-blot, dip-strip tests). When a
peroxidase substrate is reacted with a peroxidase in the presence
of a peroxide, an insoluble colored reaction product is produced,
which precipitates onto the membrane where the peroxidase is
captured. Examples of this type of substrate include TMB,
4-chloro-1-naphtol and DAB. Methods which use combinations of two
precipitating peroxidase substrates (CN/DAB, TMB/CLN) and enhancers
of dye precipitation, such as metal ions (e.g. Ni and Co), have
also been described.
[0008] However, TMB precipitating substrates do have some
shortcoming. For example, the adsorption of oxidized TMB polymers
on membranes depends on the type of molecule immobilized in the
zones, which capture the enzyme label. In some cases, due to the
high density of the reagents, the TMB polymers fail to stick
efficiently. Moreover, high concentrations of captured enzyme
labels can result in the formation of excessive precipitating
reaction products can result in diffusion outside of the zone. It
is also very common to see high background staining due to
non-specific adsorption of the enzyme onto the membrane in areas
outside of the diagnostic zones. Dyes formed by TMB polymers as
well as with other precipitating HRP substrates
(1-Chloro-2-naphtol, diaminobenzidine) are light sensitive and
quickly fade even without being exposed to direct light. All of
these drawbacks limit the applicability of TMB substrate systems
for quantitative densitometric analysis. Also, TMB substrate can
not be prepared in a dry form, which could be quickly reconstituted
with an aqueous buffer.
[0009] HRP substrates producing light insensitive indamine type
dyes as a complex of MBTH (3-methyl-2-benzothiazolinone hydrazone)
with dienophile or an aromatic nucleophile is described in U.S.
Pat. No. 5,432,285. Another HRP precipitating substrate system
utilizes a combination of two reagents: 4-CN and MBTH or
substituted p-phenylenediamine (Conyers, S M, Kidwell D A. Anal
Biochem, 1991, 192: 207-211).
[0010] Oxidative coupling of 3-(dimethyl aniline)benzoic acid
(hydrogen donor) with MBTH (3-methyl-2-benzothiazolinone hydrazone)
(oxidizable coupling reagent) was described in Ngo et al (Anal
Biochem, 1980, 105, 389-370). This method is similar to a method,
which uses 4-aminoantipyrine as an oxidative coupler with a
phenolic compound and aniline (Trinder, P., Ann. Clin. Biochem 6,
24-25 (1969)). In these methods, a hydrogen peroxide-oxidized form
of HRP reacts first with an oxidizable compound (coupler), which
then reacts quickly with a second compound (hydrogen donor) in a
reaction of electrophilic substitution. The reaction proceeds
without the participation of HRP to form strong chromophores, which
are usually soluble compounds. This method was adapted for
oxidative coupling of 3-(dimethyl aniline) benzoic acid with
3-methyl-2-benzothiazolinone hydrazone as a soluble substrate
system for plate EIA tests (Georghegan et al, J Immunol Methods,
1983, 60, 61-68). These chromogenic systems produce intense colors
that are relatively stable. However, the hydrogen donors used in
these systems are unstable in solution. In addition, the
sensitivity of this type of substrate for EIA assays is lower than
the sensitivity of the best TMB HRP substrate.
[0011] Another method for detecting peroxidases, based on a two
component dye system, was developed using leucodyes, which produce
colors on membranes in the presence of an electron transfer reagent
such as 4-hydroxyacetanilide (U.S. Pat. No. 5,024,935) and
3-aminopyrazolo heterocyclic derivatives in combination with
aniline derivatives (U.S. Pat. No. 5,457,200).
[0012] A number of U.S. patents describe oxidative coupling of
4-aminoantipyrine or sulfoMBTH with various aniline derivatives
including fluorinated derivatives (See e.g. U.S. Pat. Nos.
4,845,030 and 4,912,258).
[0013] Perhaps the most developed rapid diagnostics utilizing a
two-component oxidative coupling dye system are enzymatic tests for
the detection of low molecular weight substances such as glucose,
cholesterol, uric acid, choline, alcohol, lactate, ascorbic acid,
acetyl-CoA and certain drugs. In these systems, hydrogen peroxide
is generated when the low molecular weight substance is oxidized
with an appropriate enzyme (cholesterol oxidase, glucose oxidase,
lactate oxidase, uricase, choline oxidase, ascorbate oxidase
guanase, etc.). The hydrogen peroxide produced is then consumed by
HRP, which uses a two component dye system to produce color. The
amount of hydrogen peroxide produced correlates with the amount of
the particular low molecular weight substance and the amount of dye
generated by the HRP is based on the enzymatic conversion. The
reagents for this substrate system may be distributed throughout
the length of a diagnostic strip, so that the length of the colored
zone on the diagnostic strip correlates quantitatively with the
amount of test analyte in the sample.
[0014] Numerous patents describe two-component dye systems
utilizing various hydrogen donor/coupler combinations for analyte
detection in a strip format. The result may be visually read or
read using a reflectance spectrophotometer or photometer (U.S. Pat.
Nos. 6,858,401; 6,635,439; 6,531,322; 6,218,571; 5,972,294;
5,922,530 and 5,824,491). These tests typically require a liquid
sample. Substrates that do not contain hydrogen peroxide are stable
if prepared as a slowly soluble dry film or non-porous
materials.
[0015] Several patents describe the use of hydrogen donors
covalently immobilized onto a solid phase. For example, the
quinoline type hydrogen donor,
8-(4-amino-1-methylbutylamino)-6-methoxyquinoline (primaquine) has
been coupled to carbonyldiimidazole activated cellulosic membrane
(U.S. Pat. No. 5,556,743) and used as part of a strip test for
detecting cholesterol. A similar approach has been described for
the immobilization of an aniline derivative with amino groups on
CDI (carbonyldiimidazole) activated cellulose membrane (U.S. Pat.
No. 5,155,025). Aniline derivatives with primary amino groups such
as N-alkyl 3-oxyanilines were synthesized as insoluble polyvinyl
alcohol polymer conjugates (U.S. Pat. No. 5,409,780). Such
insoluble polymers were applied as plastic films and used as a
rapid test for testing glucose in blood or urine.
[0016] Various patents also describe various oxidative couplers
(e.g. MBTH, 4-aminoantipyrine, analogs of 4-aminoantipyrine, a
modified MBTH with increased solubility, which contains a carboxyl
group (U.S. Pat. No. 5,710,012); a salt of
6-carboxy-3-methylbenzenothiazolene hydrazone hydrate; MBTH
derivatives that are sulfonated on the ring (U.S. Pat. No.
6,242,207); 3-methyl-6(sulfonate
salt)-benzothiazolinone-(2)-hydrazone) or an N-sulfonyl
benzensulfonate derivative (U.S. Pat. No. 5,992,5300);
meta[3-methyl 2-benzothiazolinone hydrazone]N-sulfonyl
benzenesulfonate monosodium) or as dinitrobenzene derivatives (U.S.
Pat. No. 4,962,040) and 2-hydrazono-4,6,-dinitrobenzthiazolone).
Other combinations of hydrogen donor/couplers for the determination
of peroxidatively active catalysts such as amino benzidine type
hydrogen donors and substituted phenol type couplers are described
in U.S. Pat. No. 5,532,138.
[0017] The vast majority of currently available membrane-based
immunodiagnostic tests that utilize peroxidase and another enzyme
label, use principles of vertical filtration (flow through),
dip-sticks and other formats, which rely on passive diffusion. The
basic components of flow-through rapid diagnostic kits are liquid
reagents, HRP conjugates, HRP substrates and a wash buffer. A
precipitating substrate system (usually a TMB based substrate) is
typically used to detect the peroxidase activity of a bound
enzyme.
[0018] Lateral flow (LF) rapid tests with enzyme detector labels,
which generate dyes, currently represent a very small segment of
the diagnostic market. The advantages of using highly sensitive
enzyme labels are difficult to obtain in simple LF rapid tests,
which utilize only dry components. Enzyme labels require an
additional component, the substrate, and in most cases require a
more efficient washing step, which imposes additional challenges
and costs.
[0019] Certain patents describe lateral flow devices, which utilize
liquid or dry HRP conjugates and liquid TMB precipitating
substrates integrated into diagnostic cassettes as a sealed
container together with a container of wash buffer. These
containers can be perforated to initiate the flow of wash buffer
and subsequent delivery of substrate into the diagnostic zones on a
fast flow porous polyethylene matrix (U.S. Pat. Nos. 7,442,557;
6,436,722 and 5,726,010). Positive results can typically be
measured visually after about 8-10 minutes.
[0020] Certain patents describe LF strips with dual paths, one for
the delivery of any enzyme labeled analyte, and the other for the
delivery of reconstituted substrates for alkaline phosphatase or
beta-galactosidase based systems) with appropriate washing
separating these two processes (U.S. Pat. No. 6,706,539). Other
patents describe devices, which contain zones of immobilized
substrates. These zones generate color when an enzyme enters by
diffusion through a permeable barrier (U.S. Pat. No. 4,806,312).
Lipid vesicles (e.g. liposomes) loaded with enzyme substrates may
also be captured into a test zone. In the presence of a specific
analyte and enzyme label, the vesicles can release the enzyme
substrate into the test zones with the aid of a phospholipase,
which has been incorporated into a capture zone.
[0021] Commercially available dip-strip tests utilize porous or
non-porous materials to immobilize capture reagents, liquid enzyme
conjugates and substrate reagents. The whole strip or a working
portion may be incubated in a series of solutions (e.g. sample,
conjugate, washing solution and substrate).
[0022] The use of HRP as a label for conventional LF tests faces
other technical challenges. Among the most critical is the absence
of stable dry forms of peroxidase substrates containing a peroxide
compound. Also many peroxidase substrates, such as TMB, are not
very soluble. And although special additives may be used to
maintain TMB in solution, these mixtures cannot be prepared in an
appropriate dry form suitable for quick solubilization (See U.S.
Pat. No. 5,910,423). Other peroxidase substrates, which produce
precipitating products require organic solvents to maintain their
solubility, some of which are carcinogenic. Glucose oxidase
co-immobilized with capture antibodies on membranes can produce
hydrogen peroxide for HRP chromogenic reactions in the presence of
glucose. This approach was applied for quantitative analysis of
low-molecular weight analytes in competitive tests where the length
of the colored zone on the strip is a measure of the analyte
concentration (Li et al. Analyt Biochem, 1987, 166, 276-83, Zuk et
al. Clin Chem, 1985, 7, 1144-50). However, this approach has
limited analytical sensitivity.
[0023] All of the currently available substrate systems for
peroxidase produce a monochromic color, due to the precipitation of
a common dye polymer. The internal control zones and test zones on
these membranes typically only generate a color in the violet-blue
range.
[0024] Accordingly, there is a need for more sensitive peroxidase
substrate based rapid tests, which employ stable dry reagents.
SUMMARY OF INVENTION
[0025] Described herein are new highly sensitive and stable
multicolor substrate systems for the detection of peroxidases or
peroxidatively active substances. Peroxidases and peroxidatively
active substances, for example, can be: a) detector labels in
various assays for the detection of analytes, b) part of an
enzymatic cascade utilizing peroxides produced from conversion of
an analyte, or c) themselves analytes or diagnostic markers.
[0026] The systems rely on known principles of two-component dye
systems, where dye formation is the result of oxidative coupling
between compounds, which are known as hydrogen donors with electron
acceptors/couplers. These couplers are oxidized with a peroxide in
the presence of a peroxidase or a peroxidatively active
substance.
[0027] Also described herein are new stabilized forms of hydrogen
donors, referred to herein as "hydrogen donor conjugates," which
may be incorporated into various zones of a diagnostic membrane.
Reaction between a hydrogen donor conjugate and an oxidized coupler
in the presence of a peroxidase or peroxidatively active substance
will produce a particular color depending upon the chemical nature
of the particular hydrogen donor conjugate. Use of a plurality of
different hydrogen donor conjugates incorporated into diagnostic
zones on membranes allows for the detection of several analytes in
multiplexed rapid tests producing specific color for each test
analyte, which can be easily discriminated by the naked eye or with
the assistance of a spectrophotometer.
[0028] Hydrogen donor conjugates may be comprised of a hydrogen
donor compound covalently linked to a hydrophilic material. The
hydrogen donor compound for synthesis of hydrogen donor conjugates
may be an amine containing compound, for example, an aniline,
quinoline, naphtole or phenol, which is suitable for covalent
coupling, including, for example,
8-[4-amino-1-methylbutyl]-6-methoxy quinoline (PQ),
N,N-[dimethyl-1,3-phenylenediamine dihydrochloride (DMPA),
N-(1-naphthyl)ethylenediamine dihydrochloride (NED), and
N-phenylethylenediamine (PEDA).
[0029] The hydrophilic material can be a carboxyl containing
compound, such as a carboxylic polymer, a carboxyl containing
protein (e.g. a serum albumin or a serum albumin derivative) or a
carboxylate particle (e.g. a carboxylate modified latex (CML)
particle). In certain embodiments, the carboxylic polymer is a
linear polymer (e.g. polyglutamic acid, polyaspartic acid,
polyacrylic acid, polymaleic acid, polymethacrylic acid,
polyacrylamide/polyacrylic acid copolymer, polyvinyl-maleic acid
copolymer, polyacrylamide-polyethylene maleic acid copolymer and
polyacrylic-polymaleic acid copolymer. The carboxylic compound can
also be a branched oligomer, such as ethylenediamine tetraacetic
acid (EDTA) or ethylene
glycol-bis(2-aminoethylether)-N,N,N',N'-tetraacetic (EGTA) and
dendrimers with multiple carboxyl groups.
[0030] Preferred hydrogen donor conjugates are comprised of amine
hydrogen donors conjugated with a polymeric backbone, such as a
polycarboxylic polymer or protein-polycarboxylic polymer.
Conjugates may be additionally hydrophilized by incorporation of
polyethylene glycol (PEG). These hydrophilized hydrogen donor
conjugates contain multiple copies of hydrogen donors and are
easily solubilized in aqueous solutions. These donors can generate,
in a reaction of oxidative coupling, dyes with various colors,
having absorbance maximum in a range of 450-650 nm (i.e. red, rose,
light blue, dark blue, and various gradations of violet).
Additional color pallets can be obtained by mixing various hydrogen
donors at synthesis, or by mixing hydrogen donor polymer conjugates
of different hydrogen donors.
[0031] Hydrogen donor conjugates may also contain a member of a
high affinity binding pair (biotin as the most common example or
also an antigen (of an antigen/antibody pair), antibody (of a
antibody/antigen pair), nucleic acid (for example a single strand
nucleic acid, which is able to hybridize with a complementary
single strand nucleic acid) or conjugates thereof). Hydrogen donor
conjugates, which further include a member of a high affinity
binding pair may be used to capture analytes in a diagnostic tests
or for signal amplification. Alternatively, a hydrogen donor
conjugate may be mixed with a specific analyte capture reagents
(antibody, antigen, nucleic acids or conjugates thereof) and
applied together on membranes for formation of test and control
zones.
[0032] Hydrogen donor conjugates may further contain various
functional groups (e.g. carboxyl or amino), which allow for their
covalent immobilization onto various carriers, such as membranes,
non-porous solid phase and particles, or for conjugation with other
soluble reagents.
[0033] Water soluble hydrogen donor conjugates containing hydrogen
donors, polymers and protein carriers have high binding affinity to
various membranes suitable for passive adsorption such as
nitrocellulose, nylon, pure glass fiber membranes or non-porous
active solid phase materials.
[0034] Hydrogen donor polymer conjugates can be applied on
membranes alone or as a mixture with other reagents such as
antibodies, antigens or specific binding partners, to make test and
control zones on diagnostic membranes. After adsorption on
membranes, hydrogen donor conjugates produce zones that are
invisible on a white membrane background.
[0035] The amount of hydrogen donor conjugates required to generate
strong color in diagnostic zones is in most cases much lower than
the saturating concentration for membranes allowing for the mixing
of hydrogen donor conjugates and other reagents without
compromising sensitivity.
[0036] Hydrogen donor conjugates, as described herein, are very
stabile. Aqueous solutions of these hydrogen donor conjugates are
suitable for long term storage. Moreover, most of hydrogen donor
conjugates can be freeze-dried, and the resulting dry reagents can
be dissolved in water to form clear solutions. These hydrogen donor
conjugates are very stable when dried onto membranes and can be
stored for years in the presence of desiccants without a visible
reduction in dye formation.
[0037] Hydrogen donor conjugates may be prepared in particle-bound
form, which can be used for making diagnostic zones based on being
trapped into membrane pores or may be used in filtration
assays.
[0038] Also described herein are several methods for loading
hydrogen donor conjugates (with or without the addition of a member
of a high affinity binding pair) onto particles. In one method,
soluble hydrogen donor conjugates are immobilized on polystyrene
latex particles through passive adsorption. In a second method,
soluble hydrogen donor conjugates are covalently coupled via amino
or carboxyl groups to particles, which contain an appropriate
reactive group. In a third method, covalent immobilization of
hydrogen donor conjugates on particles together with PEG is
described. In a fourth method, immobilization of hydrogen donor
conjugates on particles, which are subsequently loaded with protein
and polycarboxylic polymers to further increase the density of
carboxylic groups and hydrophilicity is described.
[0039] Particles loaded with hydrogen donor conjugates and
hydrophilizing polymers and/or proteins produce stable suspensions
without a visible tendency for flocculation or formation of
aggregates. Particles loaded with hydrogen donor conjugates can be
mixed with particles, which containing a reagent, which may
selectively bind with an analyte (e.g. an antigen, antibody or
nucleic acid) and applied together onto a variety of diagnostic
membranes such as glass fiber, glass fiber with binder or porous
polyethylene. Particles incorporated into high pore membranes
withhold fast liquid flow and can be used in rapid diagnostic or
analytical tests to provide a highly sensitive readout in a very
short amount of time. The use of white particles produce
practically invisible zones when incorporated onto a membrane.
These particles can generate strong, bright colors in diagnostic
zones on membranes. The particles can also be used as suspensions
in bead filtration assays.
[0040] Another novel aspect of the described detection system is
its unique potential for application in multiplexed tests with
several control and diagnostic zones on analytical membranes. The
reaction of an oxidized coupler with a hydrogen donor conjugate
immobilized on a membrane produces a bright dye strictly in zones
with an immobilized hydrogen donor conjugate. A membrane may be
prepared to contain several test zones or control zones, each zone
containing a particular hydrogen donor conjugate or mixture of
hydrogen donor conjugates, each generating a different color as an
indication of a different analyte. Assays, which employ immobilized
hydrogen donor conjugates are absolutely free from background
staining, which happens frequently with conventional precipitating
peroxidase substrates.
[0041] The reaction, which results in dye formation may be stopped
by assay wash buffer or by using one of various stop reagents,
which effect enzyme activity, block the oxidative coupling
reaction, or both. Stop reagents do not produce a color change of
the reaction products. Dyes produced in solution or on membranes
using soluble hydrogen donor conjugates or particles are not light
sensitive. Diagnostic membranes preserve color after drying and can
be stored for a long time with only minor fading and without
requiring any special means for protection against light, thus
facilitating data interpretation and analysis.
[0042] Soluble polymeric hydrogen donor conjugates produce dyes
with a higher molar absorbance than is obtained with non-conjugated
hydrogen donors. The colored reaction products in most cases are
also soluble, which allows soluble hydrogen donor conjugates to be
used in plate-based assays.
[0043] Also described herein are stable peroxidase substrates
comprised of MBTH or an MBTH derivative and sodium perborate. MBTH
and MBTH derivatives, which provide maximum analytical sensitivity
in oxidative coupling reactions with immobilized hydrogen donors.
Certain substrates may be optimized for use as a stable liquid
reagent. Another reagent may be suitable for drying (using elevated
temperature, in vacuum or freeze drying process), including on
porous materials. Coupler/peroxide reagent dried on porous
materials can be quickly reconstituted with assay wash buffer
providing efficacy similar to the original liquid form. The
sensitivity provided by the described peroxidase substrates may be
further increased by adding an enhancer/accelerator of dye
formation such as acetaminophen.
[0044] The versatility of this new substrate system was
demonstrated by developing a variety of rapid diagnostic tests, as
further described herein. For example, certain assays utilize
lateral flow, dip-strip, flow through or passive diffusion formats
for the detection of antigens and antibodies, and direct detection
of analytes with peroxidative activity, such as hemoglobin. A
comparison of the sensitivity of the tests described herein with
that of similar rapid tests, which use a conventional label (e.g.
colloidal gold), demonstrate at least two orders of magnitude
higher sensitivity for the new tests. In addition, the new tests
require less time to complete due to the very fast kinetics of dye
formation. Due to the high sensitivity, new tests based on lateral
flow principles can effectively use fast flow diagnostic membranes.
Assay time in some cases can be reduced to 2-3 minutes. Flow
through tests require even less time. In most cases, highly
sensitive rapid tests in lateral flow or flow through formats can
be realized in 5-8 minutes. A direct comparison of the sensitivity
of new rapid tests with the sensitivity of optimized plate based
ELISA, which use the same capture and detector enzyme conjugates,
demonstrate that the instantly disclosed substrate system is more
sensitive, sometimes by an order of magnitude. The sensitivity of
the substrate system described herein also exceeds the sensitivity
of the best precipitating TMB-based HRP substrates. In addition,
assays, which employ the substrate systems described herein do not
undergo non-enzymatic side reactions, which could result in a
non-specific signal.
[0045] Rapid tests in the lateral flow format are sensitive enough
to detect 10-15 pg of antigen per ml. Some bacterial antigens can
be detected in a sample containing 10-20 cells per strip. The
sensitivity of antibody detection is in the range 10-15 pg per
strip. As a detector label, HRP can be detected in amounts as low
as about 0.1 pg/strip.
[0046] Water soluble hydrogen donor conjugates and particles loaded
with hydrogen donor conjugates do not result in non-specific
binding of enzyme labeled reagents and will not produce
false-positive results, if appropriate wash steps are followed. In
addition, negative results stay negative for a long time after
tests are completed, thus eliminating the need to immediately read
results.
[0047] Because dye is generated exclusively in diagnostic zones,
which contain immobilized hydrogen donor conjugates, and there is
no background staining or diffusion of dyes outside of the
diagnostic zones, the new substrate system also provides a
quantitative rapid test, which relies on a simple densitometric
analysis of the kinetics of dye formation in the diagnostic
zone.
[0048] Further features and advantages of the assays and reagents
described herein will be apparent from the following Detailed
Description and Claims.
BRIEF DESCRIPTION OF DRAWINGS
[0049] FIG. 1 is a schematic representation of how color is formed
utilizing immobilized hydrogen donor conjugates. An oxidizable
coupling reagent in the presence of peroxide and peroxidase reacts
with various immobilized hydrogen donor conjugates to produce
various colors depending on the type of immobilized hydrogen
donor.
[0050] FIG. 2 are photos showing the results of a simplified flow
through (FT) test using, soluble and particle-bound hydrogen donor
conjugates containing biotin spotted on pure glass fiber membrane
(Ahlstrom 111). Biotin was detected using an anti-biotin Ig-HRP
conjugate. Upon addition of MBTH/peroxide, spotted hydrogen donor
conjugates containing PQ, NED, PEDA and DMPA produced distinct
spots with red, blue and violet color with a sharper image for
particle-bound hydrogen donors. As a negative control for
non-specific reaction, an anti-human IgG-HRP conjugate was used. No
color was seen in the control membranes. Similar membranes
developed with precipitating TMB substrate produced diffuse spots
with significant background staining.
[0051] FIG. 3 shows results of simple flow through tests for
detection of anti peptide antibodies and antigen utilizing
particle-bound hydrogen donors and analyte capture reagents spotted
on Fusion 5 glass fiber membranes (3A) or porous polyethylene
matrix (3B). The test for detection of antibodies against C6 Lyme
peptide easily detected antibodies in medium titer Lyme positive
sera at dilutions exceeding 1000 times in about 2 minutes time. The
membrane contained two test zones with C6 peptides and different
hydrogen donors generating blue and violet dyes. Membranes for the
heartworm antigen test also contained three antigen capture test
zones generating blue, violet and rose dyes with a red internal
positive control spot.
[0052] FIG. 4 is a photograph showing the results of a multiplexed
lateral flow (LF) test for the detection of three analytes, one
antibody D1 and two antigens (D2, D3) in a common sera sample. Test
and control zones were prepared by spotting on porous polyethylene
strips with particle containing mixtures of hydrogen donor
conjugates and analyte capture reagents spotted a distance of 2-3
mm between each spot. A mixture of three HRP labeled reagents were
used for each analyte. Samples were sera containing one test
analyte or various combinations of the analytes. The analytes were
detected in 5-6 minutes.
[0053] FIG. 5 shows the results of a lateral flow/dip-strip test on
Fusion 5 for the detection of antibodies against cysticercosis
antigen T24 using serial dilution of one positive sample(A) in
comparison with testing for the same antigen using a plate
ELISA(B). Test lines contained particle-bound hydrogen donor
conjugates of DMPA and biotin. Positive control lines contained
particle-bound PQ and anti-HRP antibodies. Antibodies were captured
in the test lines as complexes with two antigen conjugates:
T24-StrAv and T24-HRP. The same T24 conjugates and biotin-BSA
coated plates were used for ELISA testing (FIG. 5 B). The LF/dip
strip test on Fusion 5 with an assay time of 6-8 minutes detected
antibodies against T24 antigen at dilutions of at least 20,480 fold
compared to only 12,800 fold in the QuickELISA.
[0054] FIG. 6 is a photograph showing the results of lateral flow
tests for the detection of antibodies against Lyme C6 peptide
antigen in serial dilutions of one positive sample. Porous
polyethylene (Porex 4897) strips were spotted with particle-bound
reagents. Two test spots contain particle bound DMPA and NED
hydrogen donors applied together with particles containing antigen,
C6-BSA. The positive control spot contained PQ particles and
particle-bound anti-HRP antibodies. For testing with TMB, substrate
strips were spotted with particles containing only C6-BSA (Test
spot) or anti HRP antibodies (Positive control spot). Samples were
mixed with C6-HRP and applied on strips. After washing by lateral
flow mechanism, aliquots of substrates were added onto the strips.
Upon addition of substrate containing MBTH and sodium perborate,
the two test spots produced violet (DMPA) or blue (NED) spots and
red for positive control. Strips developed with TMB substrate
produced a greenish color.
[0055] FIG. 7 is a photograph showing the results of flow through
tests for the detection of antibodies against the Lyme peptides C6
and C10. Test and positive control lines were prepared with soluble
hydrogen donor conjugates striped on a paper backed nitrocellulose
diagnostic membrane. Test lines contained DMPA (C6 test) and NED
(C10 tests) hydrogen donor conjugates mixed with C6-BSA and C10-BSA
correspondingly. The positive control zone was a mixture of a
PQ-BSA-polymer conjugate with anti-HRP antibodies. Positive Lyme
sera contained antibodies against both C6 and C10 peptides.
[0056] FIG. 8 shows the results of a comparison of the sensitivity
of lateral flow tests for the detection of antibodies against the
HIV gp41 peptide (FIG. 8A) and a corresponding ELISA test utilizing
the same peptide conjugate and detection formats (FIG. 8B). Test
and control lines contained soluble NED and PQ hydrogen donor
conjugates striped on the nitrocellulose membrane CN-95. The test
line with NED contained biotin and PQ control line anti-HRP IgG.
Serially diluted samples of HIV positive sera were combined with
conjugate mixtures containing the gp41 peptide.-StrAv and
anti-human-IgG-HRP and 10 .mu.l sample/conjugate mixture were added
on the sample pad zone on the diagnostic strips. Washed strips were
developed with 15 .mu.l MBTH/perborate substrate. Total assay time
was approximately 8 minutes. The positive control line produced a
red color, the test line a bright blue color. The new lateral flow
test detected antibody in high titer HIV positive sera at dilutions
exceeding 6 million (FIG. 8A), whereas the ELISA test with a
similar antibody detection format detected antibodies in the same
sera only at dilutions up to 400,000 (FIG. 8B)
DETAILED DESCRIPTION OF THE INVENTION
[0057] 1. General
[0058] Described herein are reagents of two component substrate
systems for peroxidative enzymes based on hydrogen donor conjugates
and stabilized couplers. Combinations of one coupler and different
hydrogen donor conjugates produce a spectrum of different colors in
a reaction of oxidative coupling in the presence of peroxidase
enzyme or a peroxidatively active substance and a peroxide compound
(FIG. 1). These stable reagents can be applied on test zones of
membranes to make various rapid membrane-based tests. In such
tests, multicolor results can be obtained, whereby test zones for
one or several analytes and internal control zones have specific
colors significantly simplifying visual reading.
[0059] Hydrogen donor conjugates are preferably stable, water
soluble and/or may be easily adsorbed onto or covalently coupled to
membranes or particles. Hydrogen donor conjugates may also contain
analyte-binding reagent or component of a high affinity binding
pair, which may participate in the specific binding of test
analyte. Alternatively hydrogen donor conjugates may be mixed with
specific analyte-capture reagents and applied together on
membranes.
[0060] Hydrogen donor conjugates may be incorporated into a variety
of assay formats such as lateral flow, flow-through, dip-strip,
passive diffusion, dot-blot, microarray and bead-filtration for
detection of various analytes, utilizing principles of enzyme
immunoassay, nucleic acid detection, direct detection of analytes
with peroxidative activity and analysis of analytes generating
peroxides under enzymatic conversion.
[0061] 2. Reagents of the Multicolor Substrate System
[0062] Numerous compounds with potential hydrogen donor activity
such as anilines, quinolines, naphtoles, napthalenes, phenols, and
benzoic acid derivatives are currently commercially available.
Among the commercially available compounds are those with primary
amino groups, carboxyl groups and hydroxyl groups, which are
suitable for covalent coupling using any of a variety of
conjugation chemistries. Most hydrogen donors are relatively
hydrophobic and some have limited solubility in aqueous
buffers.
[0063] Amine-containing hydrogen donors may be the most suitable
compounds for synthesis of hydrogen donor conjugates due to the
plurality of hydrophilic soluble polycarboxylic polymers currently
available and high efficacy and simplicity of conjugation methods
utilizing water-soluble carbodiimide chemistry.
[0064] Conjugation using water-soluble carbodiimide (EDAC) in
combination with N-hydroxysuccinimide, sulfo-N-hydroxysuccinimide
or N-hydroxybenzotriazole may be the most convenient method for
coupling of amino-containing compounds to carboxylic functional
groups and it can be accomplished with good yield in aqueous
buffers with minimal and simple purification of the final product.
For example, conjugates synthesized in aqueous buffer may be simply
purified by dialysis, hollow fiber filtration or gel-permeation
chromatography.
[0065] Extensive screening of various compounds that have primary
amino, carboxyl or hydroxyl groups (e.g. anilines, quinolines,
naptholes, phenols, halogenated phenols, benzoic acid derivatives)
suitable for covalent coupling with polymers was carried out. As a
result, many compounds were selected which showed the ability to
participate in oxidative coupling with a MBTH type coupler or other
types of couplers following covalent immobilization on
polycarboxylic polymers such as polyacrylic acid, polymaleic acid
and their co-polymers with polyacrylamide or polyethylene,
poly-glutamic and poly-aspartic acids. Most dyes formed in the
reaction of oxidative coupling with MBTH coupler have absorbance
maxima in the range 490-650 nm. Some MBTH derivatives can also be
used as efficient couplers in reactions with hydrogen donor
conjugates. Such MBTH derivatives include, but are not limited to,
the salt of 6-carboxy-3-methylbenzothiazolone hydrazone hydrate
(U.S. Pat. No. 5,710,012), the salt of
3-methyl-6-sulfonyl-2-benzothiazolinone hydrazone (U.S. Pat. No.
6,379,915), and the salt of meta [3-methyl 2-benzothiazolinone
hydrazone]N-sulfonyl-2-benzensulfonate (U.S. Pat. No.
5,563,031).
[0066] Hydrogen donors that generate dyes with high absorbency
include: 8-[4-amino-1-methylbutyl]-6-methoxy quinoline (Primaquine,
PQ), 6-amino-quinoline, 8-amino-quinoline,
N,N-[Dimethyl-1,3-phenylenediamine dihydrochloride (DMPA),
N-(1-Naphthyl) ethylenediamine dihydrochloride (NED), and
N-Phenylethylenediamine(PEDA). This list may be extended to include
certain derivatives of the compounds listed above and through
additional search of reagents. Appropriate hydrogen donors must not
be able to participate in direct oxidation with peroxide in the
presence of peroxidase. Although, some compounds that are weak
substrates for peroxidases may also be suitable hydrogen donors.
Also, compounds such as N-phenylethylenediamine, which is a very
weak hydrogen donor in non-conjugated form, may become relatively
active after becoming conjugated, for example to polycarboxylic
polymers.
[0067] Numerous compounds working as efficient hydrogen donors in a
free form and containing carboxylic groups and hydroxyl groups,
(examples are 3-(Dimethylamino)benzoic acid,
2,3,4-trihydroxybenzoic acid and 2,4,6-Tribromo-3-hydroxybenzoic
acid) chromotropic acid) were found to almost completely lose
activity as donors when reacted with oxidized couplers after having
been covalently coupled to amino-containing polymers
(poly-allilamine, poly-vinylamine, poly-lysine) or amino-modified
latex particles using water soluble carbodiimide, vinyl benzene or
epoxide conjugation chemistries.
[0068] In addition to the hydrogen donors and conjugation
chemistries described above and in the following examples, one of
skill in the art may using only routine experimentation arrive at
other hydrogen donor conjugates and different conjugation
chemistries. Conjugation of the most active hydrogen donor
compounds containing primary amino groups with polycarboxylic
polymers at high density may produce hydrogen donor conjugates with
limited solubility in aqueous buffers. These conjugates may form
high molecular weight aggregates or viscous colloid-like
substances. During oxidative coupling, the solubility of such
hydrogen donor conjugates may be further reduced, thereby producing
strongly insoluble dye aggregates.
[0069] It is important for hydrogen donor conjugates to be
water-soluble. By being water soluble, hydrogen donor conjugates
may be easily adsorbed onto membranes or particles, They are also
stable during storage and may be freeze-dried and reconstituted in
water or buffers as clear solutions.
[0070] The solubility of hydrogen donor conjugates may be enhanced,
for example, by adding various combinations of proteins, such as
bovine serum albumin (BSA); polycarboxylic oligomers and polymers,
and hydrophilic polyethylene glycol (PEG) polymers.
[0071] Pegylation is well-known as an efficient method for
increasing the solubility of various substances and is used in
numerous areas of bioconjugation (Polyethylene glycol chemistry:
biotechnical and biomedical applications, edited by J. Milton
Harris, Plenum Press, 1992). Abroad spectrum of PEG-based reagents
with various functional groups are available, such as:
mono-functional (primary amine, carboxylic thiol, aldehyde),
bi-functional cross-linking PEG, amino-functional, activated PEG
for reaction with amines, thiols, hydroxyl groups as well as
branched PEG and PEG with biotin, activated with maleimide,
succinimide or with primary amino groups, as well as PEG with BOC
protection. (Lysan Bio, Nanocs, Sigma-Aldrich, PolySciences,
ThermoScientific).
[0072] Numerous water soluble hydrophilic polycarboxylic polymers
such as polyacrylic acid, polymethacrylic acid, polymaleic acid,
copolymers of polyacrylic-maleic acid, polyacrylic
acid-polyacrylamide, poly-glutamic acid, poly-aspartic acid and
poly acrylic/maleic anhydrides, compounds with a small number of
carboxylic groups 4-16 are currently available from various
commercial sources (Sigma-Aldrich, PolySciences).
[0073] Also described are use of polycarboxylic polymers
representing polyacrylic acid of various molecular weights (MW in a
range 1,000-345,000 Da) and copolymers such as polyacrylic
acid-acrylamide, polymetacrylic acid, polyvinyl-maleic acid,
polymaleic acid, poly-glutamic acid, poly-aspartic acid and
polycarboxylic compound for covalent coupling of hydrogen donors
containing primary amino groups. To enhance solubility in aqueous
buffers, covalent coupling of hydrogen donors proceeds in a mixture
with amine--PEG polymers at an appropriate ratio of amine-hydrogen
donor/amine PEG. Amine-PEG can be used as biotin-PEG-amine for
coupling with polycarboxylic polymers simultaneously with
amine-donors. By varying the ratio between amine hydrogen donor and
amine PEG in a mixture, the degree of hydrophilization of polymer
conjugates may be controlled. Varying the molecular mass of PEG may
also impact the degree of hydrophilization of the final conjugates.
Amine-PEG, or amine-PEG-Biotin are preferred compounds with MW
between 1K and 20K (1K, 2K, 3.4K, 5K, 10K, 20K). The resulting
hydrogen donor conjugates may contain additional bioaffinity
groups, such as biotin, which can be effectively used for analyte
capture in numerous assay formats. Bioaffinity groups can be
selected from numerous compounds representing low molecular weight
substances such as peptides or nucleic acid probes. Hydrogen donors
may be loaded with bioaffinity groups at the same time as PEG
polymers are added. The resulting hydrogen donor conjugate may be
purified by simple dialysis and then may be adsorbed on membranes
or particles.
[0074] Polycarboxylic polymers may first be react with a protein
such as BSA, which may be additionally hydrophilized through
modification with PEG. For example, BSA may be modified through
amino groups using amino-reactive PEG derivatives. Amino-PEG may
also be hydrophilized through the carboxyl groups of BSA using
water soluble carbodiimide in conditions that minimize
cross-linking between BSA molecules. Both approaches provide
essential hydrophilization of BSA to maintain water solubility
after loading with polymers and hydrogen donors.
[0075] Amino-reactive PEG derivatives suitable for BSA pegylation,
include p-nitrophenyl carbonate PEG (MW 5 kDa and 10 kDa as
examples) and various succinimidyl ethers of PEG with MW 2-20 kDa.
Other amino-reactive PEG derivatives can be used for this purpose.
Typically, modification of 4-6 amino groups in BSA with PEG (out of
a total of 10-12 surface amino groups available for modification)
hydrophilizes BSA, while preserving the amino groups for coupling
with poly-carboxylic polymers. The presence of pegylated BSA also
significantly reduces cross-linking when reacted with activated of
carboxyl groups. BSA-PEG may be loaded with polycarboxylic
polymers, the latter should be activated with EDAC/NHS in a manner
which allows only partial activation (10-15% of available
carboxylic groups in polycarboxylic polymer solution). This helps
to prevent cross-linking of BSA-PEG upon reaction with an activated
polycarboxylic polymer. The coupling of amine hydrogen donors at
the next step proceeds through reaction with carboxyl groups on
conjugated polycarboxylic polymers and BSA. Covalent coupling of
amine hydrogen donors in a mixture with amine-PEG provides maximum
hydrophilization and produces conjugates that can be freeze-dried
without loss of solubility. Simple and efficient dialysis
procedures (dialysis membrane or hollow fiber cartridges with large
pore sizes, .about.25-50 kDa) may be used to purify the conjugation
products from non-conjugated polymers.
[0076] Hydrogen donors conjugates synthesized using PEG-modified,
BSA carrier have a higher binding affinity for nitrocellulose
membranes and are better at being passively adsorbed onto
polystyrene particles than polycarboxylic acid conjugates.
[0077] Carboxyl groups may also be added onto BSA-PEG for coupling
with amine donors using polycarboxylic compounds which have a
small, fixed number of carboxyl groups, such as the known
tetraacetate chelates EDTA, EGTA or similar branched compounds
containing 4, 8 or 16 (pendant) carboxyl groups (e.g. PAPAM
dendrimers from Sigma). Similar to linear polyacetic acid polymers,
activation of these oligomers for coupling with BSA-PEG preferably
should be limited to 1-2 available carboxyl groups. Despite the
lower density of hydrogen donors in this type of conjugate, they
bind to membranes with high affinity and provide relatively high
density of dyes when reacted with oxidized coupler. Alternatively,
carboxyl groups may be added into BSA-PEG using reactions with
poly-anhydrides such as polymaleic anhydride or copolymer of maleic
anhydride-polyethylene.
[0078] Many other reagents may be used for making hydrophilic
poly-carboxylic constructs suitable for coupling with amine
hydrogen donors and forming water soluble hydrogen donor
conjugates, provided that they provide the necessary balance
between hydrophilic and hydrophobic portions and do not create
non-specific binding of the detection reagents in diagnostic tests
or induce non-enzymatic oxidation of the hydrogen donors.
[0079] Water soluble hydrogen donor conjugates produced by the
methods described above are clear with only a minor residual orange
pigmentation for the PQ conjugates. After adsorption on white
membranes, these reagents become practically invisible. Solutions
of hydrogen donor conjugates can be stored for months in buffers
containing EDTA without any visible accumulation of oxidation
products or reduction in activity. Reagents dried on membranes may
be stored at room temperature for years without loss of
activity.
[0080] Upon reaction with an oxidative coupling agent, such as
MBTH, most hydrogen donor conjugates produce soluble dyes. This
property allows these reagents to be used as stable substrates for
plate-based assays.
[0081] Soluble polymer conjugates have a high density of hydrogen
donors that provide a very strong color after being adsorbed onto
membranes at concentration even significantly below the binding
capacity of the membrane. For example, to produce a strong visible
signal, BSA-PEG-Poly Glu-Donor-PEG conjugates, can be applied onto
nitrocellulose type membranes at a concentration of 0.1-0.2 mg/ml
at a rate of 1 ul/cm (0.05-0.1 ug per 5-mm strip), which is at
least 10 times below saturating concentration for the membrane. A
working concentration for striping these conjugates on a
nitrocellulose membrane is in the range of 0.5-0.8 mg/ml. Soluble
hydrogen donors can be used for making test zones on microarray
slides through passive adsorption or by covalent linking to an
amino reactive surface. Most of soluble hydrogen donor conjugates
can be passively adsorbed on pure glass fiber membranes, and some
on glass fiber membranes with binder. These hydrogen donor
conjugates can be mixed with other proteins (antigens, antibodies,
special conjugates) necessary for creation of analyte capture
systems and applied together on membranes which provide zones with
a high binding capacity for the test analytes and an ability to
generate strongly colored zones after being captured by a peroxide
or an analyte with peroxidative activity.
[0082] Hydrogen donors containing amino and carboxyl groups may be
coupled with appropriate particles, which contain carboxyl groups,
activated amino-reactive groups or amino groups. A large selection
of carboxylic and amine modified particles are commercially
available. Preferred particles have a high density of carboxyl
groups such as CML particles (Invitrogen, Thermo Scientific). CML
particles loaded with hydrogen donors maintain mono-dispersity, and
do not flocculate or produce aggregates, which could be difficult
to resuspend.
[0083] Several approaches are available for making particles loaded
with hydrogen donors. In one method, amine donors are directly
coupled with carboxylate particles, preferably together with
mono-amine-PEG or amine-PEG-Biotin so that the particles are stable
in suspension. Another method utilizes passive adsorption of
BSA-PEG-poly carboxylic acid donors-PEG conjugates on polystyrene
particles. In a further method, particles are loaded with BSA
through covalent coupling with carboxyl groups and further loaded
covalently with additional polycarboxylic polymers and then with
amine-hydrogen donor/PEG. This type of particle has a very minimal
tendency to flocculate and is easy to resuspend. Yet another method
uses CML particles and the soluble hydrogen donors are covalently
attached to the carboxyl groups of particles.
[0084] Hydrogen donors immobilized on particles (preferably in a
range of 0.4-2 uM size) can be simply incorporated into high pore
membranes as dots or lines which also contains a component of a
specific capture system for analytes e.g. (antibodies, antigens,
components of high affinity binding pairs). Glass fiber type
membranes, e.g. Fusion 5 (Whatman/GE Healthcare) developed for
application in lateral flow tests is a good membrane for receiving
particles. Many glass fiber membranes can also be used for passive
diffusion types of assays. Particles with hydrogen donors may be
applied on membranes in buffers alone or mixed with immunoassay
stabilizers or additional detergents. Particles may be applied
using an airjet-type of dispenser. Particles with immobilized
hydrogen donors may be easily incorporated into hydrophilic porous
polyethylene matrix with pore sizes of 10-50 uM (Porex) as spots or
lines. Particles associate with a porous matrix, strongly withhold
vertical or horizontal flow of various liquids through a matrix
(including solutions with high protein and detergent content)
without becoming dissociated. Particles are white and after
becoming incorporated produce zones, which are practically
invisible on white membrane backgrounds. Particles loaded with
hydrogen donor conjugates may be used in bead filtration assays to
generate an easily read signal in filter plate wells.
[0085] The high density of hydrogen donors in hydrogen donor
conjugates or on particles significantly increases the reaction
kinetics with oxidized couplers, which are produced in the
proximity of hydrogen donors by specifically captured HRP labels or
another peroxidative enzyme. Thus, the sensitivity is significantly
increased in comparison with a reaction in solution.
[0086] Contrary to most conventional HRP substrates, the dyes
produced from hydrogen donor conjugates and a coupler are not light
sensitive. As a result, developed membranes may be stored for many
days after the reaction is stopped and membrane dried. The presence
of hydrogen donor conjugates only in zones where they are applied
prevents background staining and formation of diffusion products.
The dyes have a bright color and are easily discriminated by the
naked eye. The amount of hydrogen donor, which may be incorporated
into zones on membranes is enough to produce a strong signal. An
analysis of the kinetics of dye formation can be done precisely
measured using an appropriate densitometer, thereby quantifying the
analyte.
[0087] 3. Use of Hydrogen Donor Conjugates in Rapid Diagnostic
Tests
[0088] Hydrogen donors conjugates may be used in a variety of rapid
test formats that utilize HRP as a detector label. One format,
which was the first adapted for use of an enzyme label, is the
flow-through format, also known as a vertical filtration or an
immunoconcentration test. Flow through are typically used to detect
antigens or antibodies.
[0089] Two different hydrogen donor conjugates: one using soluble
BSA-PEG-donor-PEG-PEG-Bi-conjugates and the other immobilized
particle, were used for making test and control zones on membranes.
Analyte capture reagents such as antigens (peptides, recombinant
antigens) or antibodies were co-immobilized with hydrogen donor
conjugates in corresponding test zones as spots or lines, dashed
lines or a combination of differently shaped zones on a diagnostic
membranes. All major types of membranes that adsorb reagents by
physical adsorption appears to work with the hydrogen donor
reagents. High pore nitrocellulose with or without paper backing
appears to work particularly well for this purpose. Some pure glass
fiber membranes (e.g. Ahlstrom 111) also adsorb soluble reagents
strongly enough for use in flow-through tests.
[0090] FIG. 2 shows examples of simplified versions of flow through
tests on pure glass fiber membranes where hydrogen donor conjugates
have been immobilized through passive adsorption or using
particle-bound reagents. Both produce sharp colored spots on the
membranes and unlike tests that used TMB substrates, there was no
background staining.
[0091] Glass-fiber membranes (Fusion 5, pure glass fiber) and
porous polyethylene matrix (Porex hydrophilic matrix 10-35 um pore
size) work well for making diagnostic zones for flow.-through tests
using particles loaded with hydrogen donors.
[0092] Antigen or antibodies may be immobilized on membranes
together with hydrogen donor conjugates in a free form or
conjugated to carriers. For tests that use a biotin/streptavidin
system to capture analyte, the test zones were prepared using
hydrogen donor conjugates containing biotin. Anti-HRP antibodies
may be used as an internal control zone for all tests. Anti-HRP
antibodies can bind to any HRP conjugate used as a detector
conjugate. Other reagents, which can capture conjugated HRP may
also be used for this purpose. Anti-HRP antibodies may be simply
mixed with hydrogen donor conjugates. Similar particles loaded with
analyte capture reagent or anti-HRP antibodies or another reagent
that bind detector HRP conjugate may also be used. For simultaneous
detection of several analytes on one membrane, the test and
internal control zones may be prepared with different hydrogen
donor conjugates generating different colors that may be easily
discriminated by the eye. The red color generated from the PQ
hydrogen donor conjugates are usually associated with the internal
control zone, and the violet, blue and dark blue with the test
zones. Various color pallets may can be generated by mixing various
reagents.
[0093] Typically, membranes for flow-through tests do not require
blocking after reagents have been applied, if the assay wash buffer
contains protein or detergents and a quick pre-wash step is used
before the sample/detector conjugate mixture is added. Tested
samples should be pre-diluted or used undiluted for mixing with HRP
conjugates, which contain a reagent, which recognizes the test
analyte. Sample/conjugate mixture may be applied onto diagnostic
membranes directly or through a special pre-filter. After
adsorption of all liquid, several washing steps may be carried out
using assay wash buffer in a dropper bottle. This step should
provide full removal of all unbound enzyme label. Most tests
tolerate a very high concentration of HRP (up to 10 ug/ml) without
effecting the specificity of the test. As a final step, 1-3 drops
of substrate reagent containing coupler/peroxide (optionally with
stabilizers) may be added. Color develops very quickly (within
several seconds) for samples, which have a high concentration of
test analyte, and require up to several minutes to attain maximum
sensitivity to detect analytes at very low concentrations.
Depending on the type of diagnostic membrane, the speed of
filtration and the desired sensitivity, the total assay time may
vary from 1 minute (for fast flow membranes, glass fiber or porous
polyethylene) to 10 minutes (for nitrocellulose type membranes). In
some cases, reaction times may be extended to maximize the
potential of the detection system.
[0094] Fast flowing porous polyethylene material and glass fiber
membranes allow for the development of very quick assays, while
nitrocellulose membranes (unbacked and paper backed) usually take
more time to run the tests, but in most cases, tests can be
completed within 5-6 minutes.
[0095] FIG. 3 demonstrates the results from a fast, highly
sensitive flow through test for the detection of antibodies and
antigens on Fusion 5 and porous polyethylene membranes with assay
times ranging between 2 and 5 minutes. The rapid tests have similar
or even higher sensitivity than the corresponding ELISA tests
utilizing the same capture and HRP-labeled reagents. The amount of
coupler/peroxide substrate reagent present in the liquid phase
surrounding the diagnostic zones is enough for a strong color to
develop. The kinetics of dye formation with immobilized hydrogen
donors is very quick, as all active/oxidized coupler produced
within the zone with peroxidase is immediately consumed by hydrogen
donor present in excess in the zones. This attribute significantly
reduces the risk of false positive results in adjacent zones based
on the diffusion of oxidized coupler from one zone to another. A
distance of 2-3 mm between zones is usually enough to exclude false
positive results of this type, if no excess substrate reagent is
present allowing for quick diffusion of the reactive coupler
between zones.
[0096] FIG. 4 shows the results of a multiplexed lateral flow test
for the detection of three analytes on a porous polyethylene matrix
where the test zones have various particle-bound hydrogen donor
conjugates and the analyte capture reagents are spotted closely
with a distance of 2-3 mm between each spot. A strong signal for
each analyte does not create a false positive signal in the
adjacent zones.
[0097] The absence of hydrogen donor conjugates in areas of the
diagnostic membrane other than the test and control zones,
completely eliminates background staining. In contrast, background
staining is frequently seen in tests that use conventional
precipitating HRP substrates as a result of the presence of HRP
labeled reagents on membranes outside of the diagnostic zones or
formation of excessive amounts of TMB precipitate products which
diffuses outside of the test zones. (See FIG. 2) The absence of
background staining results in a more accurate densitometric
analysis.
[0098] Liquid substrate reagent containing MBTH coupler, sodium
perborate as the peroxide compound in acidic
(acetate-citrate-borate-EDTA buffer, (pH 5.3)) is stable and can be
stored for years in a refrigerator. This substrate buffer does not
dissociate antibody/antigen complexes in diagnostic zones. The
stability of the liquid coupler/peroxide substrate reagent can be
further improved by adding additional protective compounds for the
peroxides and antioxidants, thereby preventing oxidation of the
MBTH.
[0099] The reagents disclosed herein may be used to develop
ultra-sensitive rapid tests utilizing lateral flow principles,
immunochromatographic tests or strip tests. Lateral flow tests with
an HRP label and the system described herein provides a simpler
format which uses the same stable, liquid substrate reagent as the
flow-through tests. This format can be described as lateral
flow/dip-strip. it differs from the typical lateral flow test,
which uses one liquid component, by using two liquid reagents: wash
buffer and substrate. Substrate reagents may be added into
specially designated zones on diagnostic strips through special
windows (in the strip housing) and may quickly saturate membranes
with control and test zones. As for the flow-through tests, the
active couplers generated in these zones may quickly be consumed by
hydrogen donor conjugates. Coupler/peroxide substrate reagents
maybe prepared in stable dry form on porous materials, which may be
included into diagnostic strips as special substrate pads. Dry
substrate may be quickly reconstituted upon contact with an assay
wash buffer to form a solution that is equivalent to a liquid
reagent. Special cassettes for this type of lateral flow test are
required to change the liquid flow from the wash buffer pad to the
substrate pad to the diagnostic zones by lateral flow
mechanisms.
[0100] As further described in the following examples, soluble and
particle-immobilized hydrogen donor conjugates were used to make
lateral flow tests containing multiple test zones and internal
control zones for the detection of various antigens (anthrax
protective antigen, human TSH, strep A polysaccharide, influenza A
and B antigen) and numerous serological tests for the detection of
antibodies to disease-specific peptides and recombinant antigens
(Lyme test, HIV-1, SARS, cysticercosis, taeniasis, Chagas, anthrax
and avian influenza). In some instances, direct comparative
experiments were carried out in which the sensitivity of the
lateral flow test utilizing a colloidal gold conjugate was compared
with the sensitivity of a comparable hydrogen donor conjugate based
tests.
EQUIVALENTS
[0101] The invention will be further described with reference to
the following non-limiting examples. It will be apparent to one
skilled in the art that many modifications may be made to the
embodiments described below without departing from the scope of the
invention. It is to be understood that these examples are provided
by way of illustration only and should not be considered limiting
in any way.
EXAMPLES
[0102] Materials.
[0103] Polyacrylic acid of various molecular weights, polyacrylic
acid co-polymers, polymaleic anhydride, and diamino-PEG
(polyethylene glycol) were obtained from Polysciences, Inc
(Warrington, Pa.). Various polycarboxylic polymers were obtained
from Sigma-Aldrich and PolySciences, Inc. BSA (bovine serum
albumin), EDAC (N-(3-dimethylaminopropyl)-N-ethylcarbodiimide
hydrochloride), NHS (N-hydroxy-succinimide), HyBTz
(1-hydroxy-benzotriazole), DMSO (Dimethyl sulfoxide) DMFA (Dimethyl
formamide), sodium borate, boric acid sodium hydroxide,
hydrochloric acid, MES (2-(N-morpholino) ethane sulfonic acid),
MOPS (3-(N-morpholino)propane sulfonic acid), NPC-PEG, PGA
(polyglutamic acid), EDTA (ethylenediamine tetraacetic acid), EGTA
(ethylene glycol-bis(2-aminoethylether)-N,N,N',N'-tetraacetic
acid), MBTH (3-methyl-2-benzothiazolinone hydrazone hydrochloride),
acetaminophen, sodium perborate, glycerol and the following
hydrogen donors: PQ (primaquine diphosphate
(8-[4-amino-1-methylbutyl]-6-methoxy quinoline), DMPA
(N'N'-[Dimethyl-1,3-phenylenediamine dihydrochloride), PEDA
(N-phenylethylenediamine), and NED (N-(1-naphthyl)ethylenediamine
dihydrochloride) were obtained from Sigma-Aldrich. Polyethylene
glycols with terminal amino groups (mono or bis), active ethers of
PEG, BOC-protected PEG amine or nitrophenyl carbonate PEG, and
biotin-PEG were obtained from Nektar (San Carlos, Calif.), Lysan
Bio (Arab, Ala.), Sigma-Aldrich and Thermo Scientific. Polystyrene
and hydrophilic polystyrene carboxylate-modified particles (CML)
and amino-modified polystyrene particles were purchased from
Invitrogen/Molecular Probes/Interfacial Dynamics, Bang's Lab,
Polysciences and Thermo Scientific. Diagnostic nitrocellulose
membranes were from Sartorius, Millipore or Whatman, glass fiber
membrane with binder (Fusion 5) and GF/DNA were from Whatman (GE
Healthcare). Pure glass fiber membranes were from Ahlstrom. Porous
polyethylene membranes were from Porex/Interstate specialty
products (Sutton, Mass.). Stabilization solutions (StabilZyme Guard
Choice, StabilZyme Select) were from SurModics. TMB
(3,3',5,5'-tetramethyl-benzidine) substrates were from Moss, Inc.
and KPL. Colloidal gold conjugates (StrAv-gold, protein A-gold)
were purchased from EYLabs (CA), and StrAv-HRP, Protein A-HRP,
biotin-HRP, anti-biotin-IgG-HRP conjugates, anti-HRP polyclonal
antibodies, anti-human IgG-HRP were purchased from Sigma-Aldrich
and Jackson ImmunoResearch. Dialysis membranes with various pore
sizes were purchased from Spectropor. Hollow fiber dialysis
cartridges were purchased from Polyscience and Bio-Rad.
Example 1
Direct Coupling of Hydrogen Donors with Primary Amino Groups to
Carboxylate Modified Particles
[0104] Hydrophilic carboxylate-modified latex particles (CML) with
a high density of carboxylic groups and a diameter of 0.2-3.0 uM
were washed with water and 0.1M MES buffer, pH 6.3 using
centrifugation at 14,000 rpm for 3-5 minutes using siliconized
polypropylene tubes. To a final suspension (4% solid bead volume)
of washed particles, 20-40 mM solutions of donors, or mixtures of
donors with biotin-PEG-amine (or diamino-PEG), in 0.1M MES, pH
6.3-6.8 were added. The concentration of biotin-PEG-amine or
diamino-PEG was 10% of that of hydrogen donors, usually as a
mixture, 18 mM and 2 mM, correspondingly. The final concentration
of particles was 1-2% solid. Solutions of EDAC (1M in 0.1M MES, pH
6.3) and 0.4M NHS were added into tubes to a final concentration of
EDAC and NHS in reaction mixtures, 0.1M and 0.04M, respectively.
Reactions proceeded with gentle shaking for 60-90 minutes at room
temperature. Particles were purified by several cycles of
centrifugation with subsequent vortexing, using wash buffer of 0.3M
NaCl, 50 mM sodium phosphate, 1 mM EDTA, pH 7.6 with detergent
Triton X-100 (0.1%) or fluorinated detergent PolyFox NP154, and
finally in PBS (phosphate buffer solution) with 1 mM EDTA or
StabilGuard Choice with 0.05% detergent (immunoassay stabilizer for
particles). Particles loaded with hydrogen donors by this procedure
and maintained with StabilGuard Choice stabilizer produced stable
suspensions without visible agglutination. Particles could be
stored for at least several months (or up to year or longer)
without reducing the activity or accumulating colored oxidation
products. Particles loaded with hydrogen donors are white for NED
and PEDA donors, have very light yellow/brown residual pigmentation
for PQ donors and sometimes very light violet pigmentation for DMPA
donors. Upon impregnation into white membranes at amounts that
generate strong colored dyes in reactions with an oxidizable
coupling reagent, these particles produced zones that are almost
invisible on the white background.
Example 2
Coupling of Hydrogen Donors with Carboxylate Particles Through
BSA/Polyacrylic Acid or BSA/Polymaleic Acid Spacers
[0105] Washed hydrophilic carboxylate particles prepared as
described in Example 1 were first activated with EDAC/NHS in
suspension (1-2% solid particle volume) in 0.1M MES, pH 6.3 with
0.1 M EDAC and 0.04 M NHS for 30 min. Activated particles were
centrifuged and resuspended in 0.1M MES, pH 6.8 to a concentration
of 1% solid. BSA solution in 0.1M MES, pH 6.8 was added to final
BSA concentration 5 mg/ml. Coupling reaction proceeded for 60 min
with gentle shaking Particles with immobilized BSA were washed
several times with PBS-EDTA and finally with 0.1M MES, pH 6.3. BSA
particles could be used for direct loading with hydrogen donors or
additionally modified with polyacrylic acid or polymaleic anhydride
to increase the density of carboxyl groups.
[0106] For loading onto BSA particles, polyacrylic acid (MW 2K, 6K
or 15K) was first activated at a concentration of 5% with EDAC/NHS
(0.1M/0.04M) in 0.1M MES, pH 6.3. Activation proceeded for 30 min,
followed by conjugation to BSA particles. For conjugation,
activated polyacrylic acid was added at 5 mg/ml to a 1% BSA
particle suspension and incubated for 60 min with gentle
shaking.
[0107] BSA-polyacrylic acid particles were purified by two
centrifugations using 0.1M MES, pH 6.8 as wash buffer and finally
resuspended to 2% (v/v) in the same buffer. Solutions of donors or
donors-biotin-PEG were then added to make mixtures containing 1%
particles and .about.10 mM donor or donor-biotin-PEG. EDAC and NHS
were added to final concentrations of 0.1 M and 0.04M,
respectively. Reaction proceeded for 60 minutes with shaking
Particles loaded with donors were purified as described in Example
1.
[0108] For reaction of BSA particles with polymaleic anhydride,
particles were washed twice in 0.1M borate buffer, pH 8.8 and
resuspended to a concentration of .about.2% solid. Solution of 50
mg/ml polymaleic anhydride (MW 5,000, PolySciences) in DMSO was
added at a ratio of 25 ul per 1 ml of BSA particles and incubated
for 60 min at room temperature while shaking BSA-polymaleic acid
particles were purified by centrifugation, twice with PBS and twice
with 0.1M MES, pH 6.3.
[0109] Conjugation of BSA-polymaleic acid particles with hydrogen
donors and purification was accomplished as described above for BSA
or BSA-polyacrylic acid particles. Particles modified with hydrogen
donors through BSA, BSA-polyacrylic acid and BSA-polymaleic acid
produced exceptionally stable suspensions without aggregation.
Particles loaded with hydrogen donors using BSA-polycarboxylic
polymers have a higher density of hydrogen donor as evidenced by
their activity in colorimetric tubes and membrane tests as
described in the examples below.
Example 3
Synthesis of Water Soluble Polycarboxylic Polymer-Hydrogen Donor
Conjugates
[0110] 3.1. BSA-EDTA/EGTA-Hydrogen Donors/PEG-Biotin
Conjugates.
[0111] Hydrogen donors can be coupled with BSA directly using the
EDAC/NHS activation chemistry described for the synthesis of
particle-based donors. However, higher loading of hydrogen donors
to BSA can be achieved by modifying the amino groups of BSA with a
low molecular weight, branched tetra-acetic molecule such as EDTA
and EGTA, as described below.
[0112] EDTA and EGTA at 0.25M were partially activated with 50 mM
EDAC/20 mM NHS in 0.1M MES, pH 6.3. At these concentrations,
.about.25% of the available carboxyl groups in tetracetic acid
compounds are activated. The activation reaction proceeded for 30
minutes and activated EDTA or EGTA were added immediately into
80-100 mg/ml BSA solution in 0.1M MES, pH 6.3 to make reaction
mixtures containing BSA at 40-50 mg/ml and a concentration of
activated tetra-acetate compound at 125 mM. Reaction mixtures were
incubated for 60 minutes and purified by dialysis against PBS-EDTA
and finally against 0.1M MES, pH 6.3 using a dialysis membrane with
a cut-off of 12-14 kDa.
[0113] For coupling of hydrogen donors to EDTA-BSA or EGTA-BSA,
solutions of modified BSA and hydrogen donors/amine-PEG-biotin in
0.1M MES, pH 6.3 were mixed to produce solutions containing 15-20
mg/ml modified BSA and 12 mM hydrogen donor/amine-PEG-biotin. EDAC
and then NHS were added to final concentrations of 50 mM and 20 mM,
respectively. After incubation for 60 minutes, the conjugates were
dialyzed against PBS-EDTA using a dialysis membrane with cutoff of
12-14 kDa.
[0114] 3.2. BSA-PEG-Polycarboxyl Polymer-Hydrogen Donors-PEG-Biotin
Conjugates.
[0115] Preparation of soluble hydrogen donor conjugates in this
example included three major steps: a) hydrophilization of BSA with
PEG through a partial modification of the available amino groups,
b) conjugation of PEGylated BSA with polycarboxylic polymers, and
c) conjugation of BSA-PEG-polycarboxylic polymer with hydrogen
donors/amine-PEG.
[0116] Several reagents were used for PEGylation of BSA with
partial modification of available amino groups in the protein, such
as PEG-nitrophenyl carbonate, MW 5,000 (NPC-PEG), PEG-succinimidyl
succinate (MW 10000), as well as BOC derivatives (NPC-PEG-BOC,
amine-PEG-BOC, SS-PEG-BOC).
[0117] For partial modification of amino groups in BSA with
NPC-PEG, dry NPC-PEG was added into 80-100 mg/ml BSA solution in
0.1M borate buffer, pH 8.1, at the molar ratio of 6 PEG per BSA
(0.5 mg NPC PEG MW 5000 per 1 mg BSA) and reacted at room
temperature for 3 hours. The reaction mixture was dialyzed
extensively against 2.times.PBS, 1.times.PBS and finally against
0.1M MES, pH 6.3, using a 25 kDa dialysis membrane. Alternatively,
purification was performed by hollow fiber (50 K pore size)
dialysis.
[0118] For partial modification of available amino groups of BSA
with succinimidyl PEG, DMSO solution of these reagents (10 mg/ml)
were added into BSA solution (50-60 mg/ml) in 0.1M MOPS buffer, pH
7.6, at a molar ratio of PEG/BSA of 6:1 and reacted for 1-1.5 hours
with subsequent dialysis as described above for NPC-PEG-BSA.
Reaction products were analyzed for the presence of amino groups
using a TNBS (trinitrobenzene sulfonic acid) test and by
size-exclusion HPLC.
[0119] Polyacrylic acids (MW 1,800, 2,000, 3,500, 6,000 or 15,000)
were activated with EDAC/NHS in a solution with 10% (w/v) polymer
in 0.2M MES, pH 6.3. The amount of EDAC (2M in water) and NHS (0.8M
in water) added was equivalent to activation of .about.10% of the
available carboxyl groups in a polyacrylic acid solution. The
reaction proceeded for 30 minutes, after which activated
polyacrylic acid was added to BSA-PEG solution in 0.1M MES, pH 6.3.
A typical ratio of BSA-PEG:polyacrylic acid was approximately 1:5
in a reaction mixture containing 15-25 mg/ml BSA-PEG. Reaction time
was 60 minutes at room temperature. BSA-PEG-polyacrylic acid
conjugates were purified by extensive dialysis against PBS-EDTA and
finally against 0.1M MES, pH 6.3 using a 25K dialysis membrane.
[0120] For modification of residual amino groups in BSA-PEG with
poly-maleic anhydride, thus introducing extra carboxyl groups,
PEGylated BSA was dialyzed against 0.1M borate, pH 8.8. Maleic
anhydride (MW 5,000) was added from 100 mg/ml solution in DMSO into
BSA-PEG solution (20-40 mg/ml) as a single aliquot to produce a
ratio of BSA:polymaleic anhydride of 1:20, or as three aliquots
with immediate adjustment of pH to .about.8.2 with 1N NaOH.
Mixtures with added polymaleic anhydride were incubated for 30-60
minutes and then extensively dialyzed against 2.times.PBS,
1.times.PBS and finally against 0.1M MES, pH 6.3 using a 25K
dialysis membrane.
[0121] For coupling of BSA-PEG-polycarboxylic acid with hydrogen
donors/amine-PEG-biotin or donors/amine-PEG-amine solutions at a
concentration of 18 mM/2 mM (hydrogen donor/PEG) in 0.1M MES, pH
6.3 were mixed with BSA-PEG-polycarboxylic acid conjugate in the
same buffer at a ratio of 2 volumes donor/PEG per 1 volume
BSA-PEG-polycarboxylic acid at a concentration of BSA in a range of
15-25 mg/ml. EDAC (2M in water) and NHS (0.8M in water) were added
to final concentrations of 0.1M and 0.04 M, respectively. After
60-90 minutes incubation, reaction mixtures were extensively
dialyzed against PBS-EDTA using a 25K dialysis membrane.
[0122] For further lyophilization, conjugates were dialyzed against
1 mM EDTA, pH 7.6 using a 25K dialysis membrane and freeze-dried in
glass vials. Most conjugates reconstitute quickly and completely in
PBS-EDTA or water producing clear solutions with a small residual
brownish color for PQ conjugates.
[0123] 3.3. Polyacrylic Acid-Hydrogen Donors-PEG Conjugates.
[0124] Preparation of these types of soluble hydrogen donor
conjugates involved one major step, the incubation of mixtures of
polyacrylic acid, hydrogen donors and PEG-amine (or
biotin-PEG-amine) with the activation reagents, EDAC and NHS.
[0125] In a typical protocol, mixtures were prepared containing 20
mg/ml polyacrylic acid (MW 15K, 225K, 345K), 30 mM hydrogen donors,
3 mM PEG-amine (MW 3.5K, 5K or 10K), 2 mM biotin-PEG-amine (MW 2K,
3.5K or 5K) in 0.1M MES, pH 6.3-6.7 2M EDAC and 0.8M NHS solution
in water were added to final concentrations of 0.2M and 0.08M,
respectively. Mixtures were incubated for 60-90 minutes. Conjugates
were purified by dialysis (25K membrane) against 2.times.PBS-EDTA
and 1.times.PBS-EDTA. All conjugates were clear solutions with
small brown pigmentation for PQ conjugates.
[0126] All conjugates produced invisible zones when applied on
membranes at concentrations within the binding capacity of the
membrane. All soluble hydrogen donor conjugates described above can
be stored in a liquid form at least several months, in a frozen
form or freeze-dried after dialysis against water or 1 mM EDTA, pH
7.0.
[0127] Freeze-dried preparations based on high molecular weight
polyacrylic acid can be quickly and completely reconstituted with
water or buffers to form clear solutions. Dried low molecular
weight polyacrylic acid conjugates dissolve in water more
slowly.
Example 4
Passive Adsorption of BSA-PEG-Hydrogen Donor Conjugates on
Polystyrene Particles
[0128] Polystyrene particles (0.8-0.95 uM) were washed with
PBS-EDTA by repeated centrifugation at 14,000 rpm for 6 minutes and
finally resuspended in this buffer at 5% bead volume. Particles
were loaded with BSA-PEG-donor at a ratio of 0.1-0.15 mg BSA per mg
solid particles.
[0129] For adsorption of BSA-PEG-donor, solution in PBS-EDTA was
added to particles prepared in the same buffer. Mixtures containing
approximately 1% particle volume were incubated by shaking for 1
hour and then left stationary overnight at 4.degree. C. Particles
were purified by two centrifugation washings with PBS-EDTA (with
vortexing) and finally resuspended at 2% particle volume.
Example 5
Covalent Coupling of BSA-PEG-Hydrogen Donor Conjugates with
Carboxylate-Modified Particles
[0130] 5.1 Coupling with Carboxylate Particles.
[0131] Hydrophilic carboxylate-modified polystyrene latex particles
(CML particles, 0.78-0.9 um size range, Interfacial Dynamics) were
washed with 0.1 mM MES, pH 6.5 and resuspended in this buffer.
BSA-PEG-hydrogen donor conjugates with available amino groups,
synthesized by coupling hydrogen donors/amine-PEG-amine to
BSA-PEG-polycarboxylic conjugates, were dialyzed against 0.1M MOPS,
pH 7.8. Washed particles in 0.1M MES, pH 6.5 were activated in 2%
suspension with EDAC/NHS (0.1M/0.04M) for 25 min. Activated
particles were quickly washed once by centrifugation and
resuspended in 0.1M MOPS, pH 7.8 to 2% solid. BSA-PEG-hydrogen
donors-PEG-amine conjugates were added to particle producing
mixtures containing 1% particle solid and BSA conjugate at
concentration approximately 1 mg/ml. Mixtures were incubated for 60
minutes with mild shaking and then overnight in a refrigerator,
after which they were purified by three centrifugations using
PBS-EDTA as a wash buffer. Particles were finally resuspended at 2%
solid in PBS-EDTA or additionally blocked with StabilGuard Choice
for storage. Both carboxyl latex and hydrophilic CMC latex
particles produced white stable aggregate-free suspensions, which
were easily resuspended from pellets.
[0132] 5.2 Coupling with Aminated Particles.
[0133] Carboxylate-modified latex particles as described above were
converted into amino-modified particles by reacting 1% solid
suspension CML particles with 0.25-Methylenediamine, 0.1/0.04M
EDAC/NHS, pH 6.3 for 90 minutes. Ethylendiamine-modified particles
were washed 5 times with 0.1M MES, pH 6.5. BSA-PEG-polycarboxylic
polymer-donor conjugates were synthesized as described in example
3.2 at a ratio of amine-hydrogen donor/PEG-amine to carboxyl groups
of BSA-PEG-polycarboxyl polymer allowing partial, 30-50%,
modification of available carboxyl groups on the
BSA-PEG-polycarboxylic acid polymer. For coupling of amino groups
on ethylendiamine-modified particles with BSA-PEG-hydrogen donor
conjugates, particles were mixed with BSA-PEG-polycarboxylic
polymer-donor conjugates at a ratio of 0.1-0.2 mg BSA per mg
particle solid in a suspension at 1% solid. EDAC and NHS were added
to mixture amine-particles/BSA-PEG-polycarboxylic acid
polymer-donor conjugates to a final concentration of 0.05 and 0.002
M. The reaction time was 90 minutes at shaking Particles were
washed with PBS, and PBS-EDTA.
Example 6
Synthesis of Analyte Capture Reagents and Other Supplementary
Reagents
[0134] Additional particle-based reagents were synthesized using
the same carboxylate particles as described in previous examples.
Among these particles were: biotinylated particles, particles with
covalently immobilized anti-HRP antibodies, streptavidin, glucose
oxidase, peptide and protein antigens and antibodies against
various bacterial and viral antigens, and hemoglobin. Various
methods for immobilization were used, including: activation of
carboxyl particles with EDAC/NHS, using cross-linking reagents
(maleimide/sulfhydril) for cross-linking with BSA modified
carboxylic particles, or aminated particles or activation of
aminated particles with glutaraldehyde. HRP was conjugated with
antibodies using the periodate method with reduction of the Schiff
base with sodium cyanoborohydride or using sulfhydryl reactive
cross-linking reagents.
Example 7
Oxidizable Coupling Reagents
[0135] 7.1. MBTH-peroxide solution substrate reagent was prepared
in acetate-borate-citrate buffer containing 0.1 M sodium acetate,
10 mM boric acid, 10 mM citric acid, 1 mM EDTA, adjusted to pH 5.3
with sodium hydroxide. MBTH hydrochloride was added from 40 mM
stock solution in water to a final concentration of 1, 2 or 4 mM;
sodium perborate was added to concentrations of 4 or 8 mM.
Additionally, stabilized liquid substrates were prepared by adding
1 mM acetaminophen to substrates described above. This substrate
can be used for up to two years if stored in a refrigerator.
[0136] In an accelerated stability study, the substrate
demonstrated no change in activity during a 28-day storage at room
temperature and only a 10% decrease in activity after storage for
28 days at 37.degree. C.
[0137] 7.2. MBTH-perborate substrate reagent was prepared in 0.1M
MES, 0.1M sodium borate, 1 mM EDTA, pH 5.3. MBTH and sodium
perborate were added into this buffer to a concentration of 2 mM
and 8 mM, respectively.
[0138] 0.8-ml aliquots of this substrate were lyophilized in glass
vials overnight. Dry substrate is a white, not hydroscopic, fluffy
solid, which is easily dissolved in water. A comparison of the
activity of reconstituted freeze-dried substrate with control
substrate stored as a liquid as described in Example 8 below,
detected no difference in activity.
Example 8
Analysis of the Activity of Soluble Hydrogen Donor Conjugates in
Solution
[0139] The activity of hydrogen donor conjugates in reactions with
oxidative coupling reagents was tested in microplates. BSA-hydrogen
donor conjugates and hydrogen donor-polyacetic acid were replaced
for generic hydrogen donor conjugates which cover both hydrogen
donor conjugates with BSA-polycarboxylic polymer by adding 10-20
.mu.g hydrogen donor conjugates as BSA or polyacetic acid polymer
into wells with MBTH-perborate substrate, pH 5.3, with 1 mM MBTH
and 4 mM sodium perborate. The oxidation reaction was initiated by
adding 5 .mu.l of 1 .mu.g/ml HRP solution in BSA-based immunoassay
stabilizer (StabilZyme Select, SurModics). Dye formation was
monitored by reading the absorbance spectrum of the reaction
products in a spectromax 250 spectrophotometer (Molecular Devices)
in the range of 450-650 nm.
[0140] Absorbance max for dyes produced with soluble PQ conjugates
lie in the range of 500-520 nm depending on the intensity of color,
which is visually bright red. DMPA conjugates produced dyes with
absorbance max in the range of 540-550 nm, which is visually a
gradation of violet/pink color. NED conjugates generated dyes with
absorbance maximum in the range of 570-590 nm, which is a dark blue
color. PEDA conjugates produce dyes with absorbance max of 550-570
nm, appearing as light violet color.
[0141] When reacted with MBTH, most conjugates produced dyes which
are also soluble and remained in solution even at high
concentrations of reaction products. In the absence of enzyme, most
mixtures of hydrogen donor conjugates with MBTH and peroxide have
no visible traces of spontaneous oxidation and dye formation during
long incubation times even without being protected from light.
Example 9
Testing the Activity of Particle-Immobilized Hydrogen Donors in
Solution
[0142] 20-30 .mu.l particles (0.4-2.0 um) containing hydrogen
donors were mixed with 500 .mu.l MBTH-peroxide substrate in 1.5 ml
clear Eppendorf tubes and 5 .mu.l of 1-2 .mu.g/ml
streptavidin-horse radish peroxidase (StrAv-HRP) solution was
added. The mixtures were incubated for 15 minutes while shaking and
centrifuged for 2-3 minutes at 14,000 rpm. The particle pellet
contained intensely dyed particles and the supernatant for most
particle conjugates was almost clear, indicating the absence of
non-bound fractions of hydrogen donors. Particles containing PQ
hydrogen donor had a bright red color. DMPA particles had a bright
violet color. NED particles had bright dark blue color. PEDA
particles had a light violet color. The color of dyed particles in
sediment did not change during long storage at room temperature,
even without being protected from light.
Example 10
Testing the Activity of Particle-Immobilized Hydrogen Donors on
Membranes and Other Porous Materials
[0143] 10.1 Particles with immobilized hydrogen donors and their
mixtures with other particles (e.g. with anti-HRP antibodies,
biotin, streptavidin. or glucose oxidase) were applied on Fusion 5
membranes using the reagent dispenser Linomate 5 (CAMAG). Membranes
were laminated onto a backing card with an adhesive. The
concentration of particles with immobilized hydrogen donors was
0.5-2% solid in StabilGuard Choice with 0.05-0.1% PolyFox NP-154 in
PBS-EDTA or in buffer containing 4% sucrose and 2% PEG-4000 as
stabilizers for application of particles containing immobilized
antibodies. The dispensing volume was 0.5-2.0 .mu.l/cm.
Supplementary particles, if necessary, were added in to the
striping mixture in an amount of 5-20% of hydrogen donor particles.
Membranes were dried at 45.degree. C. for 15 minutes in an oven
(food dehydrator) and cellulosic adsorbent pad material was
attached to one end of Fusion 5 membranes. Strips 4-6 mm wide were
prepared using a guillotine membrane cutter (index cutter,
Kinematic Automation).
[0144] 10.2. Particles with hydrogen donors were applied on strips,
discs or squares of glass fiber membranes (Fusion 5, Ahlstrom grade
111) and on porous polyethylene (Porex type 4897, 15-45 um pore
size, 0.062''), as spots with volumes of 1.0-3.0 .mu.l/spot
(depending on the material), using the buffer solution described
above and dried at 45.degree. C. for 15 minutes. The porous
polyethylene membrane strongly retained particles of various sizes
(0.4-3.0 uM) despite its large pore size.
[0145] 10.3. Soluble hydrogen donor conjugates and their mixtures
with other components of analyte capture systems were applied on
nitrocellulose membranes using solutions in PBS-EDTA, or
additionally containing 4% sucrose. Solutions were applied using
the reagent dispenser Linomate 5 at a dispensing volume of 0.5-1.0
.mu.l/cm. The concentration of hydrogen donor conjugates was in the
range of 0.25-1.5 mg/ml for most tests. After drying at 45.degree.
C. for 10-15 minutes, sample/wash buffer pad (Fusion 5) was
attached from one end and adsorbent pad material from the opposite
end of the backing card with approximately 1 mm of overlap. Strips
4-5 mm wide were prepared using a guillotine cutter.
[0146] For testing of reagents in a flow-through format with a
nitrocellulose type membrane, spots of soluble hydrogen
donors/capture reagents (0.3-0.6 .mu.l) were applied on squares of
nitrocellulose membrane with paper backing (FT 060, Whatman) and
dried.
[0147] 10.4. For testing of reagents in a flow-through format with
a pure glass fiber membrane, Ahlstrom 111 particles with hydrogen
donors or soluble BSA-polyacrylic acid conjugates in PBS-EDTA were
spotted (1-2 .mu.l/spot) and dried as described above. Test samples
for most analytical tests were prepared in sample diluents
containing 10% calf sera in the immunoassay stabilizer StabilZyme
Select, detergent 0.1% Triton X-100 or Tween-20 and dye orange G at
a concentration of 0.005%. Wash buffer contained BSA at 5 mg/ml, 4%
glycerol, 0.1% Triton X-100 and 1 mM EDTA in PBS, pH 7.2.
[0148] 10.5. Typical Assay Protocols for Testing Hydrogen Donor
Conjugates Applied on Fusion 5 Glass Fiber Membranes.
[0149] Sample containing HRP conjugate recognizing capture reagent,
co-immobilized with hydrogen donor particles (anti-Biotin IgG-HRP,
StrAv-HRP, Protein A/G-HRP, biotin-HRP, anti IgG-HRP) in lines was
applied on strips in the area between lines with donors/capture
reagents and wash buffer application zone. The sample volume was
20-40 .mu.l. Wash buffer was added dropwise directly on the end of
Fusion 5 or on a square of Porex porous polyethylene membrane
placed on the end of a Fusion 5 strip. An additional piece of
adsorbent pad was placed over the adsorbent pad attached to
strips.
[0150] Washing continued for 1-1.5 minutes until complete wash out
(disappearance of orange color) of Orange G dye. Substrate
solution, one 30-40 .mu.l drop, was added into the same zone as
sample or directly on lines with hydrogen donors. A strong signal
became visible several seconds after contact with substrate, and a
weak signal required several minutes for color development. The
total assay time was in the range of 1.5-6 minutes. To analyze the
kinetics of dye formation, sequential pictures were taken using a
photo camera. To stop the reaction and dye formation, extra wash
buffer or special stop solution containing 50 mM hydroxylamine and
0.5% SDS in wash buffer was added on a wash buffer pad.
[0151] For testing hydrogen donor conjugates spotted on strips of
porous polyethylene, 10-mm wide strips were laminated onto an
adhesive backing card. 50-100 .mu.l sample was added into area
behind spots. No special wash buffer pad was used. An adsorbent
piece of cellulosic membrane was placed on one end of the strip.
After sample application, wash buffer was added using a dropper
bottle until all orange G dye entered into the adsorbent pad.
Several drops of substrate were added directly on zones with
spotted reagents. Dye formation took seconds or extended for
several minutes depending on the amount of captured HRP label.
Total assay time was 1.5-8 minutes.
[0152] For testing reagents in flow-through (vertical filtration
format), squares or disks of membranes with spotted reagents were
inserted into appropriate flow-through cassettes with thick
adsorbent material below membranes, providing direct contact
between diagnostic membrane and adsorbent or through an additional
layer of porous polyethylene membrane (Porex type 4588, 90-120 um,
0.024''). Before sample application, membranes were wetted with 2-3
drops of wash buffer, and 100-200 ul of sample containing
HRP-labeled detection reagents was added. After complete absorption
of liquid sample, 4-5 aliquots of wash buffer was added using
dropper bottles allowing for the complete absorption of the
deposited solution. Then 3-4 drops of substrate were added. Dye
formation in spots took place within seconds for highly positive
signals, with read time extending up to 5 minutes for less positive
signals. At the end of incubation with substrate, membranes were
quickly washed and removed from cassettes for analysis (to prevent
false positive signals as a result of back diffusion of the
enzyme).
Example 11
Analytical Sensitivity of Hydrogen Donor Conjugates Vs. Colloidal
Gold Label in a Lateral Flow Test Format
[0153] 5-mm strips of Fusion 5 membrane with a test line containing
1.2 .mu.m CML particles with immobilized DMPA hydrogen donor and
biotin-PEG prepared as described in Examples 1 and 10.2 were tested
with serially diluted conjugates containing StrAv-gold, StrAv-HRP,
anti-biotin IgG-gold or anti-biotin IgG-HRP. Liquid samples (30
.mu.l) containing StrAv or anti-biotin antibodies in amounts
ranging from 120-0.0075 ng per sample were applied in simultaneous
experiments on two sets of strips--one for gold conjugate and the
other for HRP. The testing protocol was as described in Example
10.5.
[0154] Test Results:
[0155] the smallest amount of StrAv in StrAv-gold conjugates which
produced visible lines was around 7.5 ng/strip, whereas StrAv-HRP
could be easily detected at an amount of 0.0075 ng/ml, (i.e. 1000
times less). For anti-biotin IgG-gold conjugates, the minimal
amount of IgG for a barely visible signal was 3.75 ng/strip, while
for HRP conjugate the lines were visible with at least 0.003
ng/strip, i.e. at .about.1000-fold lower amount.
Example 12
Comparison of the Analytical Sensitivity Between Colloidal Gold and
Instant Disclosed Detection System in a Lateral Flow Format
[0156] 5-mm strips of Fusion 5 membrane with a line containing 2
.mu.m CML particles with immobilized PQ and biotin-PEG were
prepared as described in Examples 1 and 10.2. Samples containing
serially diluted StrAv-human IgG conjugate with a known
concentration of conjugated IgG in a range of 24-0.012 ng/strip
were applied to the strips. The amount of StrAv-IgG was
significantly lower than the binding capacity of biotin in the test
line. After washing, liquid protein-A-gold conjugate (30 .mu.l,
containing 6 .mu.g/ml protein A/ml) was added on the first set of
strips and 30 .mu.l HRP-protein A at a concentration of 1 .mu.g/ml
was added on a second set of strips. Strips were washed, and strips
with protein A-HRP were developed with substrate (5 minutes).
[0157] Test Results:
[0158] Protein A-gold conjugates detected IgG in amounts as low as
6 ng/strip, whereas protein A-HRP detected IgG in amounts as low as
0.012 ng/strip (i.e. 500 times lower.) The red color generated for
positive signals with PQ donors is visibly brighter than the red
color of bound gold conjugate.
Example 13
Comparison of the Analytical Sensitivity Between the Instant
Disclosed Detection System and a System Based on Precipitation of
TMB Substrate
[0159] 5-mm strips of Fusion 5 membrane with a test line containing
0.8 um CML particles with immobilized DMPA or NED hydrogen donors
and biotin-PEG were prepared as described in Examples 1 and 10.2.
30 .mu.l liquid samples containing StrAv-HRP with 3-0.0075 ng HRP
per sample were applied on strips. The same samples were analyzed
in an ELISA test using plates coated with Biotin-PEG-BSA and
ultrasensitive TMB substrate (Moss, Inc.). In ELISA experiments,
the sample volume and volume of TMB substrate were 100 .mu.l/well.
Incubation times were 15 minutes with StrAv-HRP and 4 minutes with
TMB substrate, with shaking. The reaction was stopped with 100
.mu.l/well of universal stop solution.
[0160] Test Results:
[0161] HRP in StrAv-HRP conjugate can be detected at amounts of
less than 0.75 pg/strip (25 pg/ml). Titrations of the same serially
diluted samples of StrAv-HRP conjugates on plates coated with
biotin-PEG-BSA, detected HRP at concentrations as low as 60 pg/ml.
In other words, the membrane test with hydrogen donor conjugates
were more sensitive than the microplate ELISA with the highly
sensitive TMB substrate.
Example 14
Comparison of the Analytical Sensitivity of: (a) a Commercial
Lateral Flow Test, which Uses Colloidal Gold Labels; (b) a Lateral
Flow/Dip-Stick Test, which Uses HRP Labels and Immobilized Hydrogen
Donors and (c) a Plate ELISA Test
[0162] To compare the sensitivity of a lateral flow/dip-strip test
as described herein and a commercial lateral flow test based on the
conventional colloidal gold label (BINAX NOW Strep A test),
polyclonal antibodies that were used in the commercial test were
conjugated with HRP using a periodate procedure and covalently
immobilized on 2 .mu.m carboxylate particles. As internal positive
control, polyclonal anti-HRP antibodies were conjugated with 2
.mu.m amine particles using bi-functional cross-linking reagents
(GMBS (4-Maleimidobutyric acid N-hydroxysuccinimide ester) and SATA
(N-Succinimidyl-5-acetylthioacetate)). For making the test line,
particles with anti-Strep A IgG were mixed with carboxylate
particles containing immobilized DMPA/PEG in a ratio of 1:4. For
the internal positive control line, particles with immobilized
anti-HRP IgG were mixed with CML particles containing immobilized
PQ/PEG in a ratio of 1:6. Mixtures were striped on Fusion 5
membranes laminated on adhesive backing and dried at 45.degree. C.
for 15 minutes. The areas containing test and internal positive
control lines were laminated with 14 mm clear film. 5 mm wide
strips were cut. As an adsorbent pad, thick cellulosic blotting
paper (VWR 320) was attached to Fusion 5 strips. Samples for
testing were prepared by mixing 10 .mu.l HRP conjugate (2 .mu.g/ml)
and 40 .mu.l antigen solution in sample diluent. The whole mixture
was added directly on Fusion 5 membranes, 10-15 mm below the test
line, but was not covered with clear film. Using a dropping bottle,
3 drops of wash buffer were added onto the wash buffer application
area of the membrane and 3 more drops were added over 4 minutes
(total 6 drops). After complete absorption of the wash buffer, 2
drops of substrate solution were added onto the Fusion 5 membrane
in the zone where sample/conjugate mixture was applied. After 1
minute, adsorbent pad was removed and reaction with the substrate
proceeded for 4-6 minutes. To stop the substrate reaction, a new
adsorbent pad was placed on the Fusion 5 membrane and washing
continued using ICT Wash buffer or stop solution containing SDS and
hydroxylamine. The result was read by visual evaluation and
pictures were taken soon thereafter.
[0163] As a control for the efficacy of the capture system for
Strep A antigen on Fusion 5 membrane, a special analysis was done
with detection of Strep A antigen using colloidal gold conjugates
similar to gold conjugates used in the commercial test. In this
experiment, 30 .mu.l aliquots of anti-Strep A IgG-gold conjugate
(50D units/ml) was dried on a Fusion 5 membrane about 15 mm from
the test line. At testing, sample was applied on Fusion 5 membrane
just in front of the dry gold conjugate. Wash buffer was added to
provide a complete migration of colloidal gold conjugate through
test and control lines. The control line in this experiment
contained 1.0 .mu.m an particles with covalently immobilized
anti-rabbit IgG.
[0164] For testing the commercial lateral flow test, 100 .mu.l of
sample was added onto the sample application/extraction window on
one leaf of a book-type device. After 1 minute, adhesive liner was
pealed out and the book closed. The result was read after 5
minutes.
[0165] Plate ELISA Test.
[0166] High binding polystyrene plates (Costar) were coated with
rabbit anti-Strep A IgG at 4 .mu.g/ml, and blocked with StabilZyme
Select. Samples were serially titrated into wells (100 u/well)
using sample diluents containing 10% calf sera in StabilZyme Select
and 0.1% Tween-20. Incubation time with sample was 30 minutes while
on a plate shaker. After washing with PBS-0.05% Tween-20,
anti-Strep A-IgG-HRP was added at a concentration of 0.25 .mu.g/ml.
The incubation time with the HRP conjugate was 15 minutes with
shaking. The plate was washed four times and developed with
ultrasensitive TMB one-component substrate (Moss, Inc.) for 4
minutes at shaking. The reaction was stopped with 100 .mu.l
universal stop solution and the result was read at 450 nm.
[0167] Three types of samples with Strep A antigen were used for
the analysis: a) suspension of cell culture with a known density of
cells and whole cells dried on swabs (positive control swabs), b)
extracted Strep A cells (nitrous acid and enzymatic), and c) pure
Strep A polysaccharide conjugated with BSA at known
BSA/polysaccharide ratios. As negative controls, identical aliquots
of sample diluents (or sample diluents with extraction reagents
used for sample preparation) were run in all tests.
[0168] Results:
[0169] A comparison of the detection limits after testing the
various antigenic materials in the three test formats is shown in
Table 1. The lateral flow/dip-strip test with the new substrate
system for HRP had the lowest detection limit. The rapid test
described herein has a detection limit of up to five times lower
than the detection limit of the ELISA test and 60-600 times lower
than the detection limit of the colloidal gold ICT test. Fast flow
Fusion 5 strips used for the new ICT test worked with colloidal
gold conjugates demonstrating a sensitivity of only 2 times lower
than commercial test on a slow nitrocellulose membrane.
[0170] The rapid tests disclosed herein have the ability to detect
20 Strep A cells per test or 4.5.times.10.sup.2 cells/ml in the
original sample. The detection limit for BSA-PSA conjugate is 0.8
ng/ml or 0.04 ng/strip, corresponding to a concentration of
polysaccharide of 0.013 ng/ml or 0.65 pg/strip. This amount is
equivalent to the dilution of the original BSA-PSA stock solution
(with BSA concentration 1 mg/ml) 1,024,000 times. At testing of
very high doses of antigen (10 m/ml, 2 .mu.g/ml and 1 mg/ml),
indicated no visible hook effect. Strong signal developed as a
sharp bright color line within seconds after adding the substrate.
Negative controls did not develop color after at least 15 minutes
contact time with the substrate and remain negative for a long time
if a stop reagent is applied.
TABLE-US-00001 TABLE 1 Comparison of the detection limit for Strep
A antigens at testing in NOW Strep A ICT, new ICT and ELISA.
ICT/dip- strip test New with Gold ELISA Ratio ICT/dip- conjugate
test detection Commercial strip test on strips with Ratio limit
Strep A with containing reagents Detection Commercial ICT
immobilized immobilized used limit Strep A colloidal hydrogen
hydrogen ICT ELISA/ ICT/ new gold donors donors tests new ICT ICT
Assay time 5-15 min 5-12 min 10 -15 min 60 min Limit of 250 ng/ml
0.8 ng/ml or 500 ng/ml 1.5- 2-5 300-600 detection pure or 0.04
BSA-PS 3 ng/m1 antigen (BSA- 25 ng/strip ng/strip* A/ml PS A or 50
conjugate) ng/strip Limit of 8 .times. 10.sup.4 4.2 .times.
10.sup.2 180-400 detection Strep cells/ml or cells/ml or n/a 5- 2-5
A cells 8 .times. 10.sup.3 ~20 8 .times. 10.sup.3 extracted with
cells/strip cells/strip Lys enzyme Limit of Dilution Dilution n/a
n/a n/a 60-120 detection Strep 1:16 1:1024 A positive swabs after
standard nitric acid extraction *As BSA content
Example 15
Rapid Tests for Detection of Anthrax Protective Antigen (PA) and
Human Thyroid Stimulating Hormone (hTSH)
[0171] Rapid tests for detection of two antigens, anthrax PA and
hTSH, were prepared using Fusion 5 as the diagnostic membrane and
particle-based reagents as the capture reagents for the test and
control lines. Capture monoclonal antibody against the beta subunit
of hTSH was immobilized on 0.8 .mu.m amine polystyrol latex
particles activated with glutaraldehyde or on 0.9 .mu.m carboxyl
particles conjugated with BSA and activated with GMBS. Thiolated
antibody prepared with limited SATA modification was coupled to
BSA-maleimide particles. Monoclonal anti-bacillus anthracic PA
antibody was immobilized on 0.8 .mu.m carboxyl particles activated
with EDAC/NHS as in Example 2. As detector conjugates for the
anthrax PA test, affinity purified goat IgG-HRP or recombinant ScA
fragments of antibodies conjugated with HRP were used. As a
detector reagent for the hTSH test, a monoclonal anti-alpha subunit
of hTSH and polyclonal affinity purified anti-beta subunit
antibodies conjugated with HRP were used.
[0172] Particles with capture antibodies were mixed with particles
containing immobilized hydrogen donors for making test lines on
diagnostic membranes (60% donor particles, 40% particles with
capture antibodies in 2% suspension). For the PA test, 0.6 .mu.m
CML particles were loaded with BSA-polyacrylic acid 15K and
NED/PEG. For the hTSH test, similar NED or DMPA hydrogen donor
particles were made using 0.4 .mu.m CML particles. Reagents were
striped on Fusion 5 membranes laminated on adhesive backing cards
as described in Example 14. 5-mm strips were assembled with
cellulosic adsorbent pad.
[0173] hTSH standard 1000 Units/ml and recombinant PA (63 kDa
fragment, List Biological Laboratories) were used as antigens.
Antigen dilutions for testing were made using sample diluents
containing StabilZyme Select with 10% calf sera, 0.1% Tween-20 and
Orange G as a dye. Samples of 50 .mu.l were mixed with 20 .mu.l HRP
conjugate prepared in the same diluents and after short incubation
(15-30 seconds), 30 .mu.l were transferred onto strips close to the
test line. The concentration of HRP conjugate in mixtures with
samples was 2 .mu.g/ml in the PA antigen test and 3.5 m/ml in the
hTSH test. Strips were washed over 2-3 minutes by adding drops on
the wash buffer pad attached to the low portion of the Fusion 5
membrane and developed by adding 2 drops of substrate.
[0174] Results:
[0175] The test for detecting anthrax PA antigen required 5 minutes
time. Concentrations as low as 2 ng/ml were detected. The hTSH test
required 8 minutes time. Concentrations of antigen as low as 45
pg/ml (0.21 U/ml) were detected. The sensitivity in this range is
sufficient to analyze the hTSH concentration in human blood to
diagnose hypothyroidism, normal state or hyperthyroidism.
Example 16
Rapid Test for Detection of Antibodies to the T24 Cysticercosis
Antigen on a Glass Fiber Membrane and Comparison with a Standard
ELISA Test
[0176] 1.2 .mu.m CML particles conjugated with BSA-polyacrylic
acid-DMPA/PEG-Biotin were applied at 2 .mu.l/cm to make a test line
on a Fusion 5 membrane. An internal control line was prepared using
similar particles containing PQ and PEG without biotin mixed with
particles containing anti-HRP IgG as described in Example 14.
Strips were prepared as described in Example 14
[0177] For capture of antibodies specific to anti-T24 antigen in a
test line, antigen-specific antibodies were sandwiched between
StrAv and HRP conjugates and then captured through binding of StrAv
to biotin in the test line. Recombinant T24 antigen from cysticerci
of pork worm T. solium (92 aa, MW 10,013) was conjugated with StrAv
and HRP at equimolar ratio using maleimide sulfhydryl conjugation
chemistry (this approach is described in detail in U.S. Pat. Nos.
7,125,517 and 7,262,019). Two conjugates were used as a mixture
containing 0.4 .mu.g T24 antigen per ml of each conjugate, in
diluents containing 10% calf sera in StabilZyme Select with 0.1%
Tween-20 and 0.005% orange G dye. For testing, samples were diluted
with sample diluents similar to conjugate diluents but containing
20% calf serum and 1.times.PBS. Equal volumes of diluted sample and
a mixture of two antigen conjugates (StrAv and HRP) were combined
and after a short (0.5-1 minute) incubation, 30 .mu.l was applied
on Fusion 5 strips. Strips were washed for 2-3 minutes by adding
wash buffers with droppers, after which 2 drops of Substrate
Solution were added on membranes not covered with clear film. The
substrate reaction time was 5-6 minutes; however, for samples with
high concentrations of the test analyte, the signal and internal
positive controls became visible within 30 seconds after addition
of the substrate.
[0178] ELISA versions of the test for detection of anti-T24
antibodies was run on plates coated with biotin-PEG-BSA. Diluted
samples (50 .mu.l) were added into wells and 50 .mu.l conjugate
mixture at 0.2 .mu.g/ml of T24 antigen was added. Plates were
incubated at shaking for 30 minutes, washed, and highly sensitive
TMB substrate was added. The reaction time with substrate was 4
minutes with shaking. The reaction was stopped with 100 .mu.l
universal stop solution and read at 450 nm. Samples in both tests
were panels of human sera containing samples from people afflicted
with neurocysticercosis, non-T. solium helminthic infection, and
normal human sera.
[0179] Results:
[0180] A comparison of the detection limits at testing of a
cysticercosis positive serum pool in the rapid lateral flow test
and ELISA described above show that the rapid lateral flow test can
produce positive signals at dilutions of positive sera up to 40,960
times, whereas in the ELISA test, positive signal (OD.about.0.1) is
produced at dilutions of up to 10,240 (FIG. 3). Comparison of the
rapid test and ELISA testing a panel of positive sera,
cross-reactive samples and normal sera (total 80 samples)
demonstrates that all positive samples in the ELISA test, which
included some very low positive samples with absorbance close to
the cutoff value of the test (<0.2), are positive in the rapid
test. All ELISA-negative samples are also negative in the rapid
test.
Example 17
Rapid Lateral Flow Test for Lyme Disease with C6 and C10 Peptides
on Glass Fiber Membranes
[0181] The rapid lateral flow/dip-strip test for detection of
antibodies against two diagnostic peptides of Lyme disease, C6
peptide (26 amino acids) and C10 peptide (10 amino acids), was
created using particle- and soluble polymer-conjugated hydrogen
donors and peptide conjugates. All peptide conjugates were prepared
using peptides with N-terminal cysteine. The C6 peptide was coupled
to maleimide-activated 0.78 .mu.m amine particles, prepared by
reaction with GMBS in 50 mM phosphate buffer, pH 7.6 containing 1
mM EDTA. Activated particles were washed with phosphate buffer, pH
6.5, containing 1 mM EDTA and reacted with Cys-C6 peptide at
concentration 0.5 mg/ml. C10 peptide were covalently immobilized on
0.8 .mu.m carboxylate particles loaded with BSA as described in
Example 2. Sulfhydryl-reactive BSA particles with maleleimide
groups were obtained through modification of amino groups of BSA
with GMBS in 50 mM phosphate buffer, pH 7.6, containing 1 mM EDTA.
Maleimide-activated particles were purified by two centrifugations
in 50 mM phosphate buffer, pH 6.5 with 1 mM EDTA and reacted with
Cys-C10 peptide at a concentration of 0.2 mg/ml and particle in
particle suspension at 2% solid.
[0182] Particles with immobilized C6 and C10 peptides were washed
several times and finally resuspended in StabilGuard Choice with
0.05% PolyFox NP154. Both peptides were conjugated to
maleimide-activated BSA and maleimide-activated StrAv. Ratios of
peptides to protein were as follows: C6:BSA-4:1; C6: StrAv-2:1;
C10:BSA-4:1; C10:StrAv-4:1. Mixtures of particles for making test
lines were prepared by mixing peptide-loaded particles and 0.8
.mu.m DMPA or NED particles synthesized by loading carboxylate
particles with BSA, polymaleic anhydride MW 5000 or polyacrylic
acid MW 2000 and PEG as described in Example 2. The ratio of
peptide particles to DMPA particles was 1:4. Particle suspension
(2% solid) was stripped on Fusion 5 membrane at 1.5 .mu.l/cm.
Internal positive control line containing PQ as hydrogen donor and
anti-HRP IgG was prepared as described in Example 2. Three lines
were striped with 5 mm distance: internal positive control, C6 test
containing DMPA particles and C10 test containing NED
particles.
[0183] C6 peptide was conjugated to HRP using GMBS-activated enzyme
at a ratio of peptide:HRP of .about.1.5:1. C10 peptide was
conjugated with HRP through BSA spacer using maleimide/sufhydril
chemistry, comprising C10-BSA-HRP at ratio 4:1:3 as in U.S. Pat.
No. 7,125,517. Peptide-HRP conjugates were used as solution with
peptide concentration of 0.1 .mu.g/ml, separately or mixed
together, using conjugate diluents described in previous examples.
For testing, 30 .mu.l samples were mixed with 30 .mu.l peptide-HRP
conjugate, and 30 .mu.l of the mixture was immediately transferred
onto strips. Testing protocol was similar to that described in
Example 16.1.
[0184] The ELISA test for detection of antibodies against C6 and
C10 peptides was based on capture of antibody complexes with two
peptide conjugates, peptide-StrAv and peptide-HRP, on plates coated
with biotin-PEG-BSA as in U.S. Pat. No. 7,125,517 and Example 16.
Three types of samples were used: a) affinity-purified anti-C6 IgG
and anti-C10 IgM obtained from human sera containing high titer of
anti-peptide antibodies; b) a panel of human sera with Lyme
disease; and c) normal blood donors. Affinity-purified antibodies
were spiked into normal human sera or into sample diluents
containing 20% calf sera as described above.
[0185] Results:
[0186] Lateral flow/dip-strip test for detection of anti-C6
anti-C10 antibodies on strips of Fusion 5 membrane provides strong
signal for highly positive samples within 2 minutes after adding
the sample-conjugate mixture on Fusion 5 strips. The color
development time for low positive samples is within 6 minutes.
Samples containing anti-C6, anti-C10 or their mixture induce color
formation only in corresponding specific capture zones, i.e. in the
presence of anti-C6 antibodies, only C6 test line with violet color
is visible (besides red internal positive control line). Likewise,
in the presence of anti-C10 IgM, only blue C10 test line is
visible, and both lines are visible when a mixture of C6 and C10
antibodies is present in the sample. The test is fairly resistance
to false positive signals, so the negative result stays negative
for up to 20 minutes after the substrate has been added onto the
strips. Rapid test in this assay format can detect anti-C6 and
anti-C10 antibodies in samples at concentration as low as 0.062
.mu.g/ml. A corresponding ELISA test utilizing similar detection
principles (capture antibodies as complex with two antigen
conjugates) has a slightly lower sensitivity, with detection limit
around 0.125 .mu.g/ml. Testing of a Lyme patient panel with a known
ELISA data, demonstrated that all ELISA-positive samples including
very low positive with absorbance between 0.24 and 0.12 (ELISA
cut-off), provided a positive signal in a rapid test. No false
positive signals were detected in testing normal human sera.
Samples containing antibodies against both peptides produce two
easily discriminated colors in the test lines and internal positive
control line. There is a good correlation between OD values in the
ELISA test and the intensity of band staining in the rapid
test.
Example 18
Rapid Lyme Peptide Lateral Flow/Dip-Strip Test on Fast Flow
Nitrocellulose Membrane
[0187] Both C6 and C10 peptides were conjugated to
maleimide-activated BSA and maleimide-activated StrAv. The ratio of
peptide:protein was as follows: C6:BSA-4:1, C6:StrAv-2:1,
C10:BSA-4:1, and C10: StrAv-4:1. Soluble polymer-hydrogen donor
conjugate mixtures were striped on 25 mm supported UniSart CN95
membrane (Sartorius) at 0.5 .mu.l/cm. The internal positive control
line was a mixture of PQ conjugate (BSA-PEG-polymaleic acid) and
anti-HRP IgG at concentrations of 1 mg/ml and 0.25 mg/ml,
respectively. The distance between lines was 5 mm.
[0188] The C6 test line contained mixtures in a PBS-EDTA buffer of
BSA-PEG-polyacrylic acid-DMPA-PEG-biotin and C6-BSA at 2:1 ratio,
with the BSA concentration in conjugates being 0.25 mg/ml and 0.75
mg/ml, respectively. The C10 test line mixture was made from the
same type of hydrogen donor conjugate containing NED and BSA-C10
conjugate, 4:1.
[0189] Nitrocellulose membranes were laminated onto a 90 mm
adhesive backing card, Fusion 5 membrane 25 mm was laminated as a
wick contacting a wash buffer pad in an assembled cassette, and 25
mm cellulosic membrane was attached to the nitrocellulose membrane
as an adsorbent pad. 5 mm strips were inserted into the bottom part
of three holes of the plastic cassette for the lateral flow tests.
Porous polyethylene (Porex 4785; 12-14 mm) was placed on one end of
the Fusion 5 membrane as a wash buffer application pad and
4.times.24 mm cellulosic adsorbent type 901 (Pall) was placed on
the distal end to provide additional capacity for wash buffer.
[0190] For sample testing, 15 .mu.l of sample was mixed with 15
.mu.l peptide-HRP conjugate containing Orange G dye and 12.5 .mu.l
was transferred to the nitrocellulose portion of the strip just
before the C10 test line. Ten drops of wash buffer were added onto
the wash buffer pad through the window. After complete clearance of
Orange G dye from the nitrocellulose membrane (.about.2.5-3
minutes), one drop (25 .mu.l) of substrate was added directly on to
the test lines.
[0191] Results:
[0192] The positive control line and strong and medium positive
samples produced colored lines in seconds after contact with
substrate. The rapid test utilizing lateral flow principles with an
HRP label and new substrate system applied on a fast nitrocellulose
membrane demonstrated positive results in a short time, (close to 3
minutes). Low positive samples required up to 5 minutes for color
development. Blank samples (sample diluents only) and negative
samples did not produce false-positive staining at least during
additional 5 minutes after test completion. Test lines were sharp
and bright for high positive results. All lines in the multicolor
picture had easily discriminated colors. Sharpness of lines in a
test on nitrocellulose membranes prepared by passive adsorption of
water-soluble reagents is better than in a test on glass fiber
membranes containing particle-based reagents. The sensitivity of
the new rapid Lyme test on fast nitrocellulose membrane exceeded
the sensitivity of the ELISA test of the same format, utilizing
peptide conjugates by several-fold.
Example 19
Rapid Lateral Flow Lyme Peptide Test on Porous Polyethylene
Strips
[0193] Comparison with TMB Substrate
[0194] 0.8 .mu.m particles with immobilized hydrogen donors and
their mixtures with other particles containing BSA-C6 peptide were
applied by pipette on 12.times.50 mm strips of Porex 4897 porous
polyethylene matrix. Particles for internal positive control, 1.2
.mu.m were covalently immobilized with anti HRP polyclonal
antibodies. Mixtures contained particles with immobilized hydrogen
donors 1.5% solid and 0.5% solid particles with C6-BSA or anti HRP
antibodies. In StabilGuard Choice with 0.1% PolyFox NP-154 in
PBS-EDTA and 4% sucrose. Dispensing volume was 2.0 .mu.l/cm.
Similar strips were prepared by spotting only C6-BSA particles and
control anti-HRP particles 1% solid for use with the TMB substrate
system. Strips were laminated onto backing cards with an adhesive
and dried at 45.degree. C. for 15 minutes in a food dehydrator.
Thick adsorbent material was attached to strips from the positive
control spot end. For testing, sera samples were mixed with 2
volumes of C6-HRP conjugate, 5 .mu.g/ml in conjugate diluents
containing 10% calf sera, PBS, 0.2% triton X-100 and Orange G as a
tracking dye and after a short incubation (20-30 seconds) 100 .mu.l
applied onto strips below the test spots. Strips were washed during
2-3 minutes by adding wash buffer on the end of the strips below
the sample application zone until all the tracking dye was
adsorbed. Strips with hydrogen donor particles were developed by
adding 4 drops of MBTH/sodium perborate substrate (Example 7.1) and
strips without hydrogen donors were developed by adding TMB
substrate (Moss, Inc.). Pictures were taken after 4-5 minutes.
[0195] Results: Small sera panels containing two low positive, one
medium and two strong positive tests with the new substrate system
easily detected all samples as positive, whereas the TMB test
demonstrated a false negative result for one low positive sample
and a very weak signal for another low positive sample. Spots
developed with TMB substrate were not as sharp nor easy to read as
spots produced on strips with the new substrate system. (See FIG.
6).
Example 20
Flow-Through Test for Detection of Antibodies Against C6 and C10
Peptides
[0196] Soluble reagents for detection of anti-Lyme peptide
antibodies (See Example 17) were applied for the development of a
flow-through test. In one experiment, 0.6 .mu.l of mixtures for
positive control, C6 and C10 test were applied on squares of
nitrocellulose membrane 22.times.22 mm with paper backing (Whatman
CF 060, 0.6 .mu.m pore size). In a second experiment, reagents were
applied in diagnostic membranes as lines with a short dotted middle
line for positive control and two longer solid lines at a distance
of 4 mm from the central positive control line, containing C6-BSA
and BSA-hydrogen donor conjugates. After drying, membranes were
inserted into flow-through barrel type cassettes with a round 15 mm
window on the top part. As an adsorbent, thick polyether material
was placed below the nitrocellulose membrane.
[0197] Samples were prepared by dilution (1:200) in sample diluents
containing 20% calf sera in StabilZyme Select. For preparation of
positive human sample with serial dilutions, the first dilution was
made with a sample diluent containing 20% calf sera and subsequent
dilutions with diluents containing 20% calf sera and 1:200 normal
human sera. As a detector conjugate, a F(ab')2 fragment of goat IgG
against human IgG-HRP (Jackson Immunoresearch) at a concentration
of 6 .mu.g/ml in conjugate diluents (Example 17) was used.
[0198] A 50 .mu.l sample was mixed with 50 .mu.l HRP conjugate and
after 30 seconds, incubation transferred into cassette pre-washed
with 3 drops of wash buffer. After complete adsorption of the
sample/conjugate through test membranes, cassettes were incubated
for about 1 minute and 4 drops of wash buffer were added. After
complete adsorption, washing was repeated three more times by
adding 5-6 drops of wash buffer. Finally, three drops of substrate
were added.
[0199] Results:
[0200] A flow-through test in this configuration required
approximately 4 minutes time to complete and produced sharp, free
from background staining with multicolor pictures for positive
samples (FIG. 7). In testing high positive Lyme patient samples,
positive signals can be detected at dilutions of up to 100,000
times, which is comparable to the sensitivity of the ELISA test
which uses a similar antibody detection format but requires 1.5
hours to assay.
Example 21
Lateral Flow/Dip-Strip Test for Detection of Antibodies Against HIV
Peptide
[0201] A rapid test for detecting anti-HIV-1 peptide IgG antibodies
was prepared using soluble reagents applied on the fast
nitrocellulose membrane CN95. HIV 1 immunodominant peptide antigen
from the gp 41 protein was synthesized in monobiotinylated form
through modification with Biotin-PEG-SVA MW5K. The biotinylated
PEG-peptide was mixed with SAtrAv at molar ratio 3:1 The test line
on NC95 was prepared using a soluble hydrogen donor conjugate
BSA-PEG-polyacrylic acid-NED-PEG. A mixture
StrAv-Biotin-PEG-peptide and BSA-donor conjugates at concentrations
of 0.5 mg/ml and 1 mg/ml, respectively, was striped on membranes at
1.0 .mu.l/cm. Wash buffer and adsorbent pads were prepared as
described above. For testing, HIV positive samples were diluted
with sample diluent containing 20% calf sera in StabilZyme Select
with PBS, 1 mM ETDA, 0.2% Triton X-100 and 0.1% Tween-20. Diluted
samples were mixed with equal volumes of goat anti-human IgG-Fc-HRP
conjugate at a concentration of 4 .mu.g/ml and after short
incubation (10-15 seconds) 12.5 .mu.l was transferred onto the
strip. Washing and substrate reactions were done as described
above.
[0202] An ELISA test with a similar antibody detection format was
run on plates coated with BSA-G1 peptides at 4 .mu.g/ml. Samples
were diluted with sample diluents and incubated while shaking for
30 minutes. After washing, goat anti-human IgG-Fc-HRP conjugate was
added and plates were incubated for 25 minutes while shaking Washed
wells were developed with the ultrasensitive TMB substrate (4 min
with shaking) and stopped with the Universal stop solution.
[0203] Results:
[0204] This ELISA could detect anti-gp41 peptide antibodies in one
arbitrarily selected high positive serum sample at dilutions up to
400,000 times (FIG. 8B). Lateral flow test with assay time of 8
minutes produce highly visible signals on strips at dilutions at
least 6 million (FIG. 8 A) The test could easily detect antibody in
all samples of HIV-positive panels, including very low positives at
ELISA testing. Testing of normal blood donors demonstrated no false
positive signals, as well as a high resistance to the appearance of
false positive results upon extension of read time for several
minutes. These data confirmed the high specificity of this
test,
Example 22
Rapid Test for Detection of Pseudoperoxidase Activity of Human
Hemoglobin
[0205] Rabbit anti-human hemoglobin antibodies (Medix Biochemica,
Finland) were immobilized on 0.8 .mu.m CML particles activated with
EDAC/NHS. For making test lines containing immobilized hydrogen
donor and anti-hemoglobin antibodies, particles were mixed in equal
amounts with 1.5 .mu.m CML particles loaded with DMPA/PEG. Mixtures
(2% solid) were striped on Fusion 5 membranes at 1.5 .mu.l/cm.
[0206] Standard solutions of human hemoglobin (from Sigma) were
prepared in PBS with 5 mg/ml BSA. For testing, 50 .mu.l of
hemoglobin solution in PBS-BSA was added onto strips. Strips with
attached adsorbent pad were washed by adding 6-8 drops of wash
buffer during 2 minutes and 3 drops of substrate were added close
to the capture line. Result were read after 5 minutes
[0207] Results:
[0208] Strips of fast glass fiber membrane with particles
containing hydrogen donors and particles binding human hemoglobin
produced visible color at concentrations of hemoglobin in the
sample as low as 6.25 .mu.g/ml.
Example 23
Test Utilizing Hydrogen Peroxide Generated from Glucose Oxidase
Co-Immobilized with Hydrogen Donors on Membranes or Captured
Together with Horseradish Peroxidase (HRP) Conjugates
[0209] Two types of reagents containing glucose oxidase were
prepared: a) glucose oxidase (Sigma) covalently immobilized on 1.6
.mu.m carboxyl polystyrene latex (CM) particles, and b) glucose
oxidase-HRP-T24 chimeric conjugates at ratios of 1:1:1 using
maleimide/sulfhydryl cross-linking reagents. Two types of test
lines were made on Fusion 5 membranes. One contained a mixture of
1.6 .mu.m particles with immobilized glucose oxidase and 1.2 .mu.m
carboxylate-modified polystyrene latex (CML) particles with
PQ/PEG-biotin at ratio 1:1. The second contained only CML particles
with PQ/PEG-biotin. Mixtures were striped on membrane at 2
.mu.l/cm. Strips were prepared as described above.
[0210] Two substrates were used: one as described above, containing
1 mM MBTH and 4 mM sodium perborate, and the second which had 50 mM
glucose instead of sodium perborate. Lateral flow/dip-strip tests
for detection of antibodies against cysticercosis antigen T24 were
conducted in an antibody capture format utilizing two antigen
conjugates as described above. Three versions of the rapid T24
antibody test were run in parallel. The first was identical to test
above, which used strips with particles containing PQ/biotin and a
mixture of T24-StrAv and T24-HRP conjugates for antibody capture
and standard MBTH/sodium perborate substrate. The second test used
strips with a mixture of PQ/biotin particles and glucose oxidase
particles, the same antigen conjugate mixture, and MBTH/sucrose
substrate. The third test was identical to the first, but with a
mixture of T24-StrAv/T24-glucose oxidase-HRP and MBTH/sucrose
substrate. Human sera containing antibodies against T24 antigen
were used for comparing the sensitivity of these tests
[0211] Results:
[0212] All versions of the test had similar detection limits of
serially diluted positive sera samples. The amount of hydrogen
peroxide generated by glucose oxidase/sucrose on membrane in close
proximity to hydrogen donors and captured HRP was enough for
efficient oxidation of the MBTH coupler and its coupling with
immobilized hydrogen donors. However, the kinetics of dye formation
in the test with the glucose oxidase/sucrose pair as a source of
peroxide was slightly slower. While the test with MBTH/perborate
took 3 minutes to attain a good signal intensity, the test with
glucose oxidase required about 6 minutes for color development of
the same intensity.
Example 24
Tests with Oxidizable Coupling Reagent and the-Peroxide Substrate
Dried on a Porous Material
[0213] Several methods for preparing dry forms of MBTH/sodium
perborate substrate were found. As an example, substrate prepared
in a MES-borate-EDTA drying buffer described above was applied on
squares of porous materials such as porous polyethylene (Porex
X-4897), glass fiber membranes, Fusion 5 and GF/DNA (Whatman) and
dried in a freeze-dryer overnight. Alternatively, porous materials
saturated with liquid substrate were kept for 15 minutes at
45.degree. C. and then in a vacuum oven at room temperature
overnight in the presence of desiccant.
[0214] Pieces of materials with dry substrates were placed on
strips after completion of washing and substrates were eluted by
adding wash buffer in a volume corresponding to a liquid-absorbing
capacity of material with dry substrate.
[0215] Results:
[0216] Substrate dried on porous materials such as porous
polyethylene and glass fiber membrane preserved activity and could
be quickly eluted using wash buffer with low buffering capacity and
delivered into diagnostic zones for chromogenic reaction with
immobilized hydrogen donors. The activity of substrates dried on
some porous materials was comparable to the activity of the
original liquid form. Substrate dried on porous materials is
suitable for long storage if packed in the presence of desiccant
and protected from light.
INCORPORATION BY REFERENCE
[0217] The contents of all cited references including literature
references, issued patents, published or non published patent
applications as cited throughout this application are hereby
expressly incorporated by reference. Additionally, the following
references are expressly incorporated herein by reference: U.S.
Pat. No. 5,556,743 Gibboni et al.; U.S. Pat. No. 4,999,287 Allen et
al.; U.S. Pat. No. 5,155,025 Allen et al.; U.S. Pat. No. 5,409,780
Schrier et al.; EP Patent No. 0345460 Abbott Laboratories; U.S.
Pat. No. 5,432,285 Spyros Theodoropulos; T. T Ngo and H. M. Lenhoff
(Anal Biochem, 1980, 105, 389-370); U.S. Pat. No. 5,726,010 IDEXX;
U.S. Pat. No. 6,436,722 IDEXX; U.S. Pat. No. 7,442,557 IDEXX;
Polyethyleneglycol chemistry, Biotechnical and biomedical
applications, Ed by J. Milton Harris, Plenum Press, 1992; Conyers,
S M, Kidwell D A. Anal Biochem, 1991, 192: 207-211; U.S. Pat. No.
6,960,323 Guo S. X. et al.; Georghegan et al, J Immunol Methods,
1983, 60, 61-68; U.S. Pat. No. 6,635,439 Morrison et al.; U.S. Pat.
No. 5,824,491 Priest et al.; U.S. Pat. No. 5,972,294 Smith et al.;
U.S. Pat. No. 5,922,530 Yu Yeung; U.S. Pat. No. 6,218,571 Xiaoling
Zheng at al.; U.S. Pat. No. 6,858,401 Phillips at al.; U.S. Pat.
No. 6,531,322 Jurik at al.; U.S. Pat. No. 5,532,138 Singh S. at
al.; U.S. Pat. No. 5,024,935 McClune et al.; U.S. Pat. No.
5,457,200 Zimmermann at al.; U.S. Pat. No. 5,910,423 Yamazaki et
al.; U.S. Pat. No. 5,710,012; U.S. Pat. No. 6,242,207; U.S. Pat.
No. 5,992,530; U.S. Pat. No. 4,962,040; U.S. Pat. No. 5,532,138;
U.S. Pat. No. 5,563,031; U.S. Pat. No. 6,379,915; U.S. Pat. No.
5,710,012; Li et al. Analyt Biochem, 1987, 166, 276-83; Zuk et al.
Clin Chem, 1985, 7, 1144-50; and U.S. Pat. No. 6,706,539.
EQUIVALENTS
[0218] Those skilled in the art will recognize, or be able to
ascertain using no more than routine experimentation, many
equivalents to the specific embodiments of the invention described
herein. It is, therefore, to be understood that the foregoing
embodiments are presented by way of example only and that, within
the scope of the appended claims and equivalents thereto, the
invention may be practiced otherwise than as specifically described
and claimed.
* * * * *